National Academies Press: OpenBook
« Previous: 12 Issues in the Assessment of Dose Response
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

References

Abbas, R., and J.W. Fisher. 1997. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol. Appl. Pharmacol. 147(1):15-30.

Abbas, R.R., C.S. Seckel, J.K. Kidney, and J.W. Fisher. 1996. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab. Dispos. 24(12):1340-1346.

ACS (American Cancer Society). 2006. Statistics 2006. American Cancer Society [online]. Available: http://www.cancer.org/docroot/stt/stt_0.asp [accessed June 21, 2006].

Adgate, J.L., L.E. Eberly, C. Stroebel, E.D. Pellizzari, and K. Sexton. 2004. Personal, indoor, and outdoor VOC exposures in a probability sample of children. J. Expo. Anal. Environ. Epidemiol. 14(Suppl. 1):S4-S13.

Albanese, R.A., H.T. Banks, M.V. Evans, and L.K. Potter. 2002. Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue. Bull. Math. Biol. 64(1):97-131.

Alefeld, G., and J. Herzberger. 1983. Introduction to Interval Computations. New York: Academic Press.

Allen, B.C., and J.W. Fisher. 1993. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal. 13(1):71-86.

Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994a. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol. 23(4):487-495.

Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994b. Dose-response assessment for developmental toxicity. III. Statistical models. Fundam. Appl. Toxicol. 23(4):496-509.

Altuntas, T.G., R.A. Zager, and E.D. Kharasch. 2003. Cytotoxicity of S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in a human proximal tubular cell line. Toxicol. Appl. Pharmacol. 193(1): 55-65.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Altuntas, T.G., B.S. Park, and E.D. Kharasch. 2004. Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A). Chem. Res. Toxicol. 17(3):435-445.

Anand, S.S., M.M. Mumtaz, and H.M. Mehendale. 2005a. Dose-dependent liver tissue repair after chloroform plus trichloroethylene binary mixture. Basic Clin. Pharmacol. Toxicol. 96(6):436-444.

Anand, S.S., M.M. Mumtaz, and H.M. Mehendale. 2005b. Dose-dependent liver regeneration in chloroform, trichloroethylene and allyl alcohol ternary mixture hepatotoxicity in rats. Arch. Toxicol. 79(11):671-682.

Andelman, J.B., S.M. Meyers, and L.C. Wilder. 1986. Volatilization of organic chemicals from indoor uses of water. Pp. 323-330 in Chemicals in the Environment, J.N. Lester, R. Perry, and R.M. Sterritt, eds. London: Selper Ltd.

Anders, M.W., A.A. Elfarra, and L.H. Lash. 1987. Cellular effects of reactive intermediates: Nephrotoxicity of S-conjugates of amino acids. Arch. Toxicol. 60(1-3):103-108.

Andersen, M.E., J.J. Mills, and R.L. Jirtle. 1995. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 102(1-2):223-237.

Anna, C.H., R.R. Maronpot, M.A. Pereira, J.F. Foley, D.E. Malarkey, and M.W. Anderson. 1994. ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis 15(10):2255-2261.

Anttila, A., E. Pukkala, M. Sallmen, S. Hernberg, and K. Hemminki. 1995. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J. Occup. Environ. Med. 37(7):797-806.

Aranyi, C., W.J. O’Shea, J.A. Graham, and F.J. Miller. 1986. The effects of inhalation of organic chemical air contaminants on murine lung host defenses. Fundam. Appl. Toxicol. 6(4):713-720.

Arito, H., M. Takahashi, H. Tsuruta, and T. Ishikawa. 1994. Age-related changes in electrocardiographic responses to trichloroethylene inhalation in conscious rats. Ind. Health 32(3):129-144.

Arms, A.D., and C.C. Travis. 1988. Reference Physiological Parameters in Pharmacokinetic Modeling. EPA/600/6-88/004. Office of Health and Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC. July 1988.

Armstrong, B.G. 1990. The effects of measurement errors on relative risk regressions. Am. J. Epidemiol. 132(6):1176-1184.

Asal, N.R., J.R. Geyer, D.R. Risser, E.T. Lee, S. Kadamani, and N. Cherng. 1988. Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions. Cancer Detect. Prev. 13(3-4):263-279.

Aschengrau, A., D. Ozonoff, C. Paulu, P. Coogan, R. Vezina, T. Heeren, and V. Zhang. 1993. Cancer risk and tetrachloroethylene-contaminated drinking water in Massachusetts. Arch. Environ. Health. 48(5):284-292.

Astrand, I. 1975. Uptake of solvents in the blood and tissues of man [review]. Scand. J. Work Environ. Health 1(4):199-218.

ATSDR (Agency for Toxic Substances and Disease Registry). 1990. Toxicological Profile for cis-, trans-1,2-Dichloroethene (Update Draft). U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA.

ATSDR (Agency for Toxic Substances and Disease Registry). 1995. Toxicological Profile for 1,1,1-Trichloroethane (Update). U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA.

ATSDR (Agency for Toxic Substances and Disease Registry). 1996. Toxicological Profile for 1,2-Dichloroethene. U.S. Department of Health and Human Services, Public Health Ser-

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

vice, Agency for Toxic Substances and Disease Registry, Atlanta, GA. [online]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp87.html [accessed May 9, 2006].

ATSDR (Agency for Toxic Substances and Disease Registry). 1997a. Toxicological Profile for Trichloroethylene (Update). U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA [online]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp19.html [accessed March 2, 2006].

ATSDR (Agency for Toxic Substances and Disease Registry). 1997b. Toxicological Profile for Tetrachloroethylene. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA [online]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp18.html [accessed May 9, 2006].

ATSDR (Agency for Toxic Substances and Disease Regristry). 1998. Volatile Organic Compounds in Drinking Water and Adverse Pregnancy Outcomes: United States Marine Corps Base, Camp Lejeune, North Carolina. Agency for Toxic Substances and Disease Registry, Atlanta, GA. August 1998 [online]. Available: http://www.atsdr.cdc.gov/HS/lejeune/ [accessed March 15, 2006].

ATSDR (Agency for Toxic Substances and Disease Regristry). 2003. Progress Report: Survey of Specific Childhood Cancers and Birth Defects Among Children Whose Mothers Were Pregnant While Living at U.S. Marine Corps Base Camp Lejeune, North Carolina, 1968-1985. Agency for Toxic Substances and Disease Registry, Atlanta, GA. July 2003 [online]. Available: http://www.atsdr.cdc.gov/sites/lejeune/lejeunehealthsurvey.pdf [accessed May 15, 2006].

Aupérin, A., S. Benhamou, C. Ory-Paoletti, and R. Flamant. 1994. Occupational risk factors for renal cell carcinoma: A case-control study. Occup. Environ. Med. 51(6):426-428.

Axelson, O., K. Andersson, C. Hogstedt, B. Holmberg, G. Molina, and A. de Verdier. 1978. A cohort study on trichloroethylene exposure and cancer mortality. J. Occup. Med. 20(3):194-196.

Axelson, O., A. Selden, K. Andersson, and C. Hogstedt. 1994. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J. Occup. Med. 36(5):556-562.

Backe, B. 1993. Maternal smoking and age. Effect on birthweight and risk for small-for-gestational age births. Acta Obstet. Gynecol. Scand. 72(3):172-176.

Bai, C.L., and N.H. Stacey. 1993. Mechanism of trichloroethylene-induced elevation of individual serum bile acids. II. In vitro and in vivo interference by trichloroethylene with bile acid transport in isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 121(2):296-302.

Bailer, A.J., L.T. Stayner, R.J. Smith, E.D. Kuempel, and M.M. Prince. 1997. Estimating benchmark concentrations and other non-cancer endpoints in epidemiology studies. Risk Anal. 17(6):771-780.

Baillargeon, J. 2001. Characteristics of the healthy worker effect. Occup. Med. 16(2): 359-366.

Baraona, E., L. Shoichet, K. Navder, and C.S. Lieber. 2002a. Mediation by nitric oxide of the stimulatory effects of ethanol on blood flow. Life Sci. 70(25):2987-2995.

Baraona, E., G.A. Zeballos, L. Shoichet, K.M. Mak, and C.S. Lieber. 2002b. Ethanol consumption increases nitric oxide production in rats, and its peroxynitrite-mediated toxicity is attenuated by polyenylphosphatidylcholine. Alcohol Clin. Exp. Res. 26(6):883-889.

Bardodej, Z., and J. Vyskocil. 1956. The problem of trichloroethylene in occupational medicine: Trichloroethylene metabolism and its effect on the nervous system evaluated as a means of hygienic control. AMA Arch. Ind. Health 13(6):581-592.

Barret, L., S. Torch, Y. Usson, B. Gonthier, and R. Saxod. 1991. A morphometric evaluation of the effects of trichloroethylene and dichloroacetylene on the rat mental nerve. Preliminary results. Neurosci. Lett. 131(2):141-144.

Barret, L., S. Torch, C.L. Leray, L. Sarlieve, and R. Saxod. 1992. Morphometric and biochemi-

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

cal studies in trigeminal nerve of rat after trichloroethylene or dichlororacetylene oral administration. Neurotoxicology 13(3):601-614.

Barrett, D.A., and N. Rutter. 1994. Transdermal delivery and the premature neonate. Crit. Rev. Ther. Drug Carrier Syst. 11(1):1-30.

Barshop, B.A., R.K. Naviaux, K.A. McGowan, F. Levine, W.L. Nyhan, A. Loupis-Geller, and R.H. Haas. 2004. Chronic treatment of mitochondrial disease patients with dichloroacetate. Mol. Genet. Metab. 83(1-2):138-149.

Bartell, S.M. 2005. Risk assessment. Chapter 32 in Environmental Health: From Local to Global, H. Frumkin, ed. San Francisco, CA: Jossey-Bass.

Barton, H.A., C.D. Flemming, and J.C. Lipscomb. 1996. Evaluating human variability in chemical risk assessment: Hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene. Toxicology 111(1-3):271-287.

Bartonicek, V., and V. Teisinger. 1962. Effect of tetraethyl thiuram disulphide (disulfiram) on metabolism of trichloroethylene in man. Br. J. Ind. Med. 19:216-221.

Beaumont, J.J., and N.E. Breslow. 1981. Power considerations in epidemiologic studies of vinyl chloride workers. Am. J. Epidemiol. 114(5):725-734.

Beckett, G.J., A.F. Howie, R. Hume, B. Matharoo, C. Hiley, P. Jones, and R.C. Strange. 1990. Human glutathione S-transferases: Radioimmunoassay studies on the expression of alpha-, mu- and pi-class isoenzymes in developing lung and kidney. Biochim. Biophys. Acta 1036(3):176-182.

Beliveau, M., R. Tardif, and K. Krishnan. 2003. Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. Toxicol. Appl. Pharmacol. 189(3):221-232.

Berger, T., and C.M. Horner. 2003. In vivo exposure of female rats to toxicants may affect oocyte quality. Reprod. Toxicol. 17(3):273-281.

Berger, T., M.G. Miller, and C.M. Horner. 2000. In vitro fertilization after in vivo treatment of rats with three reproductive toxicants. Reprod. Toxicol. 14(1):45-53.

Bernauer, U., G. Birner, W. Dekant, and D. Henschler. 1996. Biotransformation of trichloroethene: Dose dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation. Arch. Toxicol. 70(6):338-346.

Bernstine, J.B., A.E. Meyer, and H.B. Hayman. 1954. Maternal and fetal blood estimation following the administration of chloral hydrate during labour. J. Obstet. Gynaecol. Br. Emp. 61(5):683-685.

Beroud, C., G. Collod-Beroud, C. Boileau, T. Soussi, and C. Junien. 2000. UMD (Universal mutation database): A generic software to build and analyze locus-specific databases. Hum. Mutat. 15(1):86-94.

Birner, G., S. Vamvakas, W. Dekant, and D. Henschler. 1993. Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L- cysteine is a urinary metabolite after occupational 1,1, 2-trichloroethene exposure in humans: Implications for the risk of trichloroethene exposure. Environ. Health Perspect. 99:281-284.

Birner, G., M. Werner, M.M. Ott, and W. Dekant. 1995. Sex differences in hexachlorobutadiene biotransformation and nephrotoxicity. Toxicol. Appl. Pharmacol. 132(2):203-212.

Birner, G., M. Werner, E. Rosner, C. Mehler, and W. Dekant. 1998. Biotransformation, excretion, and nephrotoxicity of the hexachlorobutadiene metabolite (E)-N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine sulfoxide. Chem. Res. Toxicol. 11(7):750-757.

Blain, L., P. Lachapelle, and S. Molotchnikoff. 1992. Evoked potentials are modified by long term exposure to trichloroethylene. Neurotoxicology 13(1):203-206.

Blair, A., P. Hartge, P.A. Stewart, M. McAdams, and J. Lubin. 1998. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: Extended follow up. Occup. Environ. Med. 55(3):161-171.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Bloemen, L.J., and J. Tomenson. 1995. Increased incidence of renal cell tumours in a cohort of cardboard workers exposed to trichloroethylene. Arch. Toxicol. 70(2):129-133.

Bloemen, L.J., A.C. Monster, S. Kezic, J.N. Commandeur, H. Veulemans, N.P. Vermeulen, and J.W. Wilmer. 2001. Study on the cytochrome P-450- and glutathione-dependent biotransformation of trichloroethylene in humans. Int. Arch. Occup. Environ. Health 74(2):102-108.

Blossom, S.J., N.R. Pumford, and K.M. Gilbert. 2004. Activation and attenuation of apoptosis of CD4+ T cells following in vivo exposure to two common environmental toxicants, trichloroacetaldehyde hydrate and trichloroacetic acid. J. Autoimmun. 23(3):211-220.

Board, P.G. 1981. Biochemical genetics of glutathione-S-transferase in man. Am. J. Hum. Genet. 33(1):36-43.

Board, P., M. Coggan, P. Johnston, V. Ross, T. Suzuki, and G. Webb. 1990. Genetic heterogeneity of the human glutathione transferases: A complex of gene families. Pharmacol. Ther. 48(3):357-369.

Bogen, K.T., B.W. Colston, Jr., and L.K. Machicao. 1992. Dermal absorption of dilute aqueous chloroform, trichloroethylene, and tetra-chloroethylene in hairless guinea pigs. Fundam. Appl. Toxicol. 18(1):30-39.

Boice, J.D., and J.K. McLaughlin. 2001. Errors in TCE analysis. Environ. Health Perspect. 109(3):A108-A109.

Boice, J.D., Jr., D.E. Marano, J.P. Fryzek, C.J. Sadler, and J.K. McLaughlin. 1999. Mortality among aircraft manufacturing workers. Occup. Environ. Med. 56(9):581-597.

Bois, F.Y. 2000a. Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics. Environ. Health Perspect. 108(Suppl. 2):307-316.

Bois, F.Y. 2000b. Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. Environ. Health Perspect. 108(Suppl. 2):275-282.

Bois, F.Y., and D.R. Maszle. 1997. MCSIM: A simulation program. J. Stat. Software 2(9) [online]. Available: http://www.jstatsoft.org/v02/i09/ [accessed March 28, 2006].

Bolt, H.M., M. Lammert, S. Selinski, and T. Brüning. 2004. Urinary alpha1-microglobulin excretion as biomarker of renal toxicity in trichloroethylene-exposed persons. Int. Arch. Occup. Environ. Health 77(3):186-190.

Borak, J., M. Russi, and J.P. Puglisi. 2000. Meta-analysis of TCE carcinogenicity. Environ. Health Perspect. 108(12):A542-A544.

Bosgra, S., W. Mennes, and W. Seinen. 2005. Proceedings in uncovering the mechanism behind peroxisome proliferator-induced hepatocarcinogenesis. Toxicology 206(3):309-323.

Bouyer, J., and D. Hemon. 1993. Retrospective evaluation of occupational exposures in population-based case-control studies: General overview with special attention to job exposure matrices. Int. J. Epidemiol. 22(Suppl. 2):S57-S64.

Bove, F., Y. Shim, and P. Zeitz. 2002. Drinking water contaminants and adverse pregnancy outcomes: A review. Environ. Health Perspect. 110(Suppl. 1):61-74.

Bove, F.J., M.C. Fulcomer, J.B. Klotz, J. Esmart, E.M. Dufficy, and J.E. Savrin. 1995. Public drinking water contamination and birth outcomes. Am. J. Epidemiol. 141(9):850-862.

Bovenzi, M., F. Barbone, A. Betta, M. Tommasini, and W. Versini. 1995. Scleroderma and occupational exposure. Scand. J. Work Environ. Health 21(4):289-292.

Bovenzi, M., F. Barbone, F.E. Pisa, A. Betta, L. Romeo, A. Tonello, D. Biasi, and P. Caramaschi. 2004. A case-control study of occupational exposures and systemic sclerosis. Int. Arch. Occup. Environ. Health 77(1):10-16.

Boyer, A.S., W.T. Finch, and R.B. Runyan. 2000. Trichloroethylene inhibits development of embryonic heart valve precursors in vitro. Toxicol. Sci. 53(1):109-117.

Boyes, W.K., P.J. Bushnell, K.M. Crofton, M. Evans, and J.E. Simmons. 2000. Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario. Environ. Health Perspect. 108(Suppl. 2):317-322.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Boyes, W.K., M. Bercegeay, J.S. Ali, T. Krantz, J. McGee, M. Evans, J.H. Raymer, P.J. Bushnell, and J.E. Simmons. 2003. Dose-based duration adjustments for the effects of inhaled trichloroethylene on rat visual function. Toxicol. Sci. 76(1):121-130.

Brambilla, G., and A. Martelli. 2004. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens. Toxicology 196(1-2):1-19.

Brashear, W.T., C.T. Bishop, and R. Abbas. 1997. Electrospray analysis of biological samples for trace amounts of trichloroacetic acid, dichloroacetic acid, and monochloroacetic acid. J. Anal. Toxicol. 21(5):330-334.

Brauch, H., G. Weirich, M.A. Hornauer, S. Storkel, T. Wohl, and T. Bruning. 1999. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J. Natl. Cancer Inst. 91(10):854-861.

Brauch, H., G. Weirich, B. Klein, S. Rabstein, H.M. Bolt, and T. Bruning. 2004. VHL mutations in renal cell cancer: Does occupational exposure to trichloroethylene make a difference? Toxicol. Lett. 151(1):301-310.

Brenner, H., and O. Gefeller. 1993. Use of the positive predictive value to correct for disease misclassification in epidemiologic studies. Am. J. Epidemiol. 138(11):1007-1015.

Bringmann, G., R. God, S. Fahr, D. Feineis, K. Fornadi, and F. Fornadi. 1999. Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline in human blood after intake of the hypnotic chloral hydrate. Anal. Biochem. 270(1):167-175.

Briving, C., I. Jacobson, A. Hamberger, P. Kjellstrand, K.G. Haglid, and L.E. Rosengren. 1986. Chronic effects of perchloroethylene and trichloroethylene on the gerbil brain amino acids and glutathione. Neurotoxicology 7(1):101-108.

Bross, G., D. DiFranceisco, and M.E. Desmond. 1983. The effect of low dosages of trichloroethylene on chick development. Toxicology 28(4):283-294.

Brown, R.P., M.D. Delp, S.L. Lindstedt, L.B. Rhomberg, and R.P. Beliles. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13(4):407-484.

Brüning, T., and H.M. Bolt. 2000. Renal toxicity and carcinogenicity of trichloroethylene: Key results, mechanisms, and controversies. Crit. Rev. Toxicol. 30(3):253-285.

Brüning, T., G. Weirich, M.A. Hornauer, H. Hofler, and H. Brauch. 1997a. Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene. Arch. Toxicol. 71(5):332-335.

Brüning, T., M. Lammert, M. Kempkes, R. Thier, K. Golka, and H.M. Bolt. 1997b. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch. Toxicol. 71(9):596-599.

Brüning, T., S. Vamvakas, V. Makropoulos, and G. Birner. 1998. Acute intoxication with trichloroethene: Clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage. Toxicol. Sci. 41(2):157-165.

Brüning, T., H. Mann, H. Melzer, A.G. Sundberg, and H.M. Bolt. 1999a. Pathological excretion patterns of urinary proteins in renal cell cancer patients exposed to trichloroethylene. Occup. Med. (Lond) 49(5):299-305.

Brüning, T., A.G. Sundberg, G. Birner, M. Lammert, H.M. Bolt, E.L. Appelkvist, R. Nilsson, and G. Dallner. 1999b. Glutathione transferase alpha as a marker for tubular damage after trichloroethylene exposure. Arch. Toxicol. 73(4):246-254.

Brüning, T., B. Pesch, B. Wiesenhutter, S. Rabstein, M. Lammert, A. Baumuller, and H.M. Bolt. 2003. Renal cell cancer risk and occupational exposure to trichloroethylene: Results of a consecutive case-control study in Arnsberg, Germany. Am. J. Ind. Med. 43(3):274-285.

Brzezinski, M.R., H. Boutelet-Bochan, R.E. Person, A.G. Fantel, and M.R. Juchau. 1999. Catalytic activity and quantitation of cytochrome P-450 2E1 in prenatal human brain. J. Pharmacol. Exp. Ther. 289(3):1648-1653.

Buben, J.A., and E.J. O’Flaherty. 1985. Delineation of the role of metabolism in the hepato-

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

toxicity of trichloroethylene and perchloroethylene: A dose-effect study. Toxicol. Appl. Pharmacol. 78(1):105-122.

Buckpitt, A., A.M. Chang, A. Weir, L. Van Winke, X. Duan, R. Philpot, and C. Plopper. 1995. Relationship of cytochrome P450 activity to Clara cell toxicity. IV. Metabolism of naphthalene to naphthalene oxide in microdissected airways from mice, rats and hamsters. Mol. Pharmacol. 47(1):74-81.

Budowsky, E.I. 1976. The mechanism of the mutagenic action of hydroxylamines. Prog. Nucl. Acid Res. Mol. Biol. 16:125-188.

Bull, R.J. 2000. Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. Environ. Health Perspect. 108(Suppl. 2):241-259.

Bull, R.J., I.M. Sanchez, M.A. Nelson, J.L. Larson, and A.L. Lansing. 1990. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63(3):341-359.

Bull, R.J., G.A. Orner, R.S. Cheng, L. Stillwell, A.J. Stauber, L.B. Sasser, M.K. Lingohr, and B.D. Thrall. 2002. Contribution of dichloroacetate and trichloroacetate to liver tumor induction in mice by trichloroethylene. Toxicol. Appl. Pharmacol. 182(1):55-65.

Bull, R.J., L.B. Sasser, and X.C. Lei. 2004. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice. Toxicology 199(2-3):169-183.

Bunce, N.J., and U.A. Schneider. 1994. Chemical lifetimes of chlorinated aliphatic priority pollutants in the Canadian troposphere. J. Photochem. Photobiol. A 81:93-101.

Burmaster, D.E. 1982. The new pollution-groundwater contamination. Environment 24(2):6-36.

Bushnell, P.J., and W.M. Oshiro. 2000. Behavioral components of tolerance to repeated inhalation of trichloroethylene (TCE) in rats. Neurotoxicol. Teratol. 22(2):221-229.

Butler, M.A., M. Iwasaki, FP. Guengerich, and F.F. Kadlubar. 1989. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA 86(20):7696-7700.

Byers, V.S., A.S. Levin, D.M. Ozonoff, and R.W. Baldwin. 1988. Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukemia. Cancer Immunol. Immunother. 27(1):77-81.

Byington, K.H., and K.C. Leibman. 1965. Metabolism of trichloroethylene in liver microsomes. II. Identification of the reaction product as chloral hydrate. Mol. Pharmacol. 1(3):247-254.

Cai, H., and F.P. Guengerich. 2000. Acylation of protein lysines by trichloroethylene oxide. Chem. Res. Toxicol. 13(5):327-335.

Cai, H., and F.P. Guengerich. 2001. Reaction of trichloroethylene and trichloroethylene oxide with cytochrome P450 enzymes: Inactivation and sites of modification. Chem. Res. Toxicol. 14(4):451-458.

Cakmak, A., A. Ekici, M. Ekici, M. Arslan, A. Iteginli, E. Kurtipek, and T. Kara. 2004. Respiratory findings in gun factory workers exposed to solvents. Respir. Med. 98(1):52-56.

Carlson, G.P. 1974. Enhancement of the hepatotoxicity of trichloroethylene by inducers of drug metabolism. Res. Commun. Chem. Path. Pharmacol. 7(3):637-640.

Caro, A.A., and A.I. Cederbaum. 2004. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu. Rev. Pharmacol. Toxicol. 44:27-42.

Carpenter, S.P., J.M. Lasker, and J.L. Raucy. 1996. Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Mol. Pharmacol. 49(2):260-268.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Carter, J.H., H.W. Carter, and A.B. DeAngelo. 1995. Biochemical, pathologic and morphometric alterations induced in male B6C3F1 mouse liver by short-term exposure to dichloroacetic acid. Toxicol. Lett. 81(1):55-71.

Carter, J.H., H.W. Carter, J.A. Deddens, B.M. Hurst, M.H. George, and A.B. DeAngelo. 2003. A 2-year dose-response study of lesion sequences during hepatocellular carcinogenesis in the male B6C3F(1) mouse given the drinking water chemical dichloroacetic acid. Environ. Health Perspect. 111(1):53-64.

Cattley, R.C., R.T. Miller, and J.C. Corton. 1995. Peroxisome proliferators: Potential role of altered hepatocyte growth and differentiation in tumor development. Prog. Clin. Biol. Res. 391:295-303.

Cavanagh, J.B., and P.H. Buxton. 1989. Trichloroethylene cranial neuropathy: Is it really a toxic neuropathy or does it activate latent herpes virus? J. Neurol. Neurosururg. Psychiatry 52(3):297-303.

Chang, Y.M., C.F. Tai, S.C. Yang, C.J. Chen, T.S. Shih, R.S. Lin, and S.H. Liou. 2003. A cohort mortality study of workers exposed to chlorinated organic solvents in Taiwan. Ann. Epidemiol. 13(9):652-660.

Chen, H.H., Y.R. Lin, Q.G. Peng, and M.H. Chan. 2005. Effects of trichloroethylene and perchloroethylene on muscle contractile responses and epithelial prostaglandin release and acetylcholinesterase activity in swine trachea. Toxicol. Sci. 83(1):149-154.

Chen, Y., J. Cai, M.W. Anders, J.L. Stevens, and D.P. Jones. 2001. Role of mitochondrial dysfunction in S-(1,2-dichlorovinyl)-l-cysteine-induced apoptosis. Toxicol. Appl. Pharmacol. 170(3):172-180.

Cherrie, J.W., H. Kromhout, and S. Semple. 2001. The importance of reliable exposure estimates in deciding whether trichloroethylene can cause kidney cancer [letter]. J. Cancer Res. Clin. Oncol. 127(6):400-404.

Chia, S.E., C.N. Ong., M.F. Tsakok, and A. Ho. 1996. Semen parameters of workers exposured to trichloroethylene. Reprod. Toxicol. 10(4):295-299.

Chia, S.E., V.H. Goh, and C.N. Ong. 1997. Endocrine profiles of male workers with exposure to trichloroethylene. Am. J. Ind. Med. 32(2):217-222.

Choi, B.C. 1992. Definition, sources, magnitude, effect modifiers, and strategies of reduction of the healthy worker effect. J. Occup. Med. 34(10):979-988.

Chow, W.H., G. Gridley, J.K. McLaughlin, J.S. Mandel, S. Wacholder, W.J. Blot, S. Niwa, and J.F. Fraumeni, Jr. 1994. Protein intake and risk of renal cell cancer. J. Nat. Cancer Inst. 86(15):1131-1139.

Clewell, H.J., and K.S. Crump. 2005. Quantitative estimates of risk for noncancer endpoints. Risk Anal. 25(2):285-289.

Clewell, H.J., III, P.R. Gentry, J.M. Gearhart, B.C. Allen, T.R. Covington, and M.E. Andersen. 1995. Applying Mechanistic Information, Pharmacokinetic Modeling, and Margin of Exposure Evaluations in a Novel Risk Assessment for Trichloroethylene and Its Active Carcinogenic Metabolites: Chloral Hydrate, Trichloroacetic Acid, Dichloroacetic Acid, and Dichlorovinylcysteine. Prepared for OSHA Directorate of Health Standards Programs and U. S. Environmental Protection Agency Office of Health and Environmental Assessment. January 31, 1995.

Clewell, H.J., P.R. Gentry, T.R. Covington, and J.M. Gearhart. 2000. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Health Perspect. 108(Suppl. 2):283-305.

Clewell, R.A., E.A. Merrill, K.O. Yu, D.A. Mahle, T.R. Sterner, D.R. Mattie, P.J. Robinson, J.W. Fisher, and J.M. Gearhart. 2003a. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: A physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat. Toxicol. Sci. 73(2):235-255.

Clewell, R.A., E.A. Merrill, K.O. Yu, D.A. Mahle, T.R. Sterner, J.W. Fisher, and J.M. Gearhart.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

2003b. Predicting neonatal perchlorate dose and inhibition of iodide uptake in the rat during lactation using physiologically-based pharmacokinetic modeling. Toxicol. Sci. 74(2):416-436.

Coberly, S., D.J. Oudiz, J.W. Overstreet, and L.M. Wiley. 1992. Effects of maternal exposure to trichloroethylene (TCE) on cell proliferation in the mouse preimplantation embryo. Reprod. Toxicol. 6(3):241-245.

Cohen, B.L., and G.A. Colditz. 1994. Tests of the linear-no threshold theory for lung cancer induced by exposure to radon. Environ. Res. 64(1):65-89.

Cohen, S.M., M.E. Meek, J.E. Klaunig, D.E. Patton, and P.A. Fenner-Crisp. 2003. The human relevance of information on carcinogenic modes of action: Overview. Crit. Rev. Toxicol. 33(6):581-589.

Cohn, P., J. Klotz, F. Bove, M. Berkowitz, and J. Fagliano. 1994. Drinking water contamination and the incidence of leukemia and Non-Hodgkin’s lymphoma. Environ. Health Perspect. 102(6-7):556-561.

Collier, J.M., O. Selmin, P.D. Johnson, and R.B. Runyan. 2003. Trichloroethylene effects on gene expression during cardiac development. Birth Defects Res. A. Clin. Mol. Teratol. 67(7):488-495.

Colt, J.S., and A. Blair. 1998. Partental occupational exposures and risk of childhood cancer. Environ. Health Perspect. 106(Suppl. 3):909-925.

Commandeur, J.N., and N.P. Vermeulen. 1990. Identification of N-acetyl(2.2-dichlorovinyl)and N-acetyl(1,2-dichlorovinyl)-L-cysteine as two regioisomeric mercapturic acids of trichloroethylene in the rat. Chem. Res. Toxicol. 3(3):212-218.

Committee of Principal Investigators. 1980. WHO cooperative trial on primary prevention of ischaemic heart disease using clofribrate to lower serum cholesterol: Mortality follow-up. Lancet 2(8191):379-385.

Committee of Principal Investigators. 1984. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: Final mortality follow-up. Lancet 2(8403):600-604.

Cooper, A.J. 2004. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants. Neurochem. Int. 44(8):557-577.

Cooper, J.R., and P.J. Friedman. 1958. The enzymic oxidation of chloral hydrate to trichloroacetic acid. Biochem. Pharmacol. 1:76-82.

Copeland, K.T., H. Checkoway, A.J. McMichael, and R.H. Holbrook. 1977. Bias due to misclassification in the estimation of relative risk. Am. J. Epidemiol. 105(5):488-495.

Corbett, T.H., R.G. Cornell, J.L. Endres, and K. Lieding. 1974. Birth defects among children of nurse-anesthetists. Anesthesiology 41(4):341-344.

Cornford, D., L. Csato, D.J. Evans, and M. Opper. 2004. Bayesian analysis of the scatterometer wind retrieval inverse problem: Some new approaches. J. Roy. Stat. Soc. B 66(3):606-626.

Corton, J.C., and P.J. Lapinskas. 2005. Peroxisome proliferator-activated receptors: Mediators of phthalate ester-induced effects in the male reproductive tract? Toxicol. Sci. 83(1):4-17.

Corton, J.C., S.P. Anderson, and A. Stauber. 2000a. Central role of peroxisome proliferatoractivated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40:491-518.

Corton, J.C., P.J. Lapinskas, and F.J.Gonzalez. 2000b. Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutat. Res. 448(2):139-151.

Cory-Slechta, D.A. 1989. Behavioral measures of neurotoxicity. Neurotoxicology 10(2): 271-295.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Cosby, N.C., and W.R. Dukelow. 1992. Toxicology of maternally ingested trichloroethylene (TCE) on embryonal and fetal development in mice and of TCE metabolites on in vitro fertilization. Fundam. Appl. Toxicol. 19(2):268-274.

Costa, G., F. Merletti, and N. Segnan. 1989. A mortality cohort study in a north Italian aircraft factory. Br. J. Ind. Med. 46(10):738-743.

Coutelle, C., B. Hohn, M. Benesova, C.M. Oneta, P. Quattrochi, H.J. Roth, H. SchmidtGayk, A. Schneeweiss, G. Bastert, and H.K. Seitz. 2004. Risk factors in alcohol associated breast cancer: Alcohol dehydrogenase polymorphism and estrogens. Int. J. Oncol. 25(4):1127-1132.

Crofton, K.M., and X. Zhao. 1993. Mid-frequency hearing loss in rats following inhalation exposure to trichloroethylene: Evidence from reflex modification audiometry. Neurotoxicol. Teratol. 15(6):413-423.

Crofton, K.M., T.L. Lassiter, and C.S. Rebert. 1994. Solvent-induced ototoxicity in rats: An atypical selective mid-frequency hearing deficit. Hear. Res. 80(1):25-30.

Cronk, C.E., M.E. Malloy, A.N. Pelech, R.E. Miller, S.A. Meyer, M. Cowell, and D.G. McCarver. 2003. Completeness of state administrative databases for surveillance of congenital heart disease. Birth Defects Res. A Clin. Mol. Teratol. 67(9):597-603.

Crump, K.S. 1984. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 4(5):854-871.

Crump, K.S., D.G. Hoel, C.H. Langley, and R. Peto. 1976. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 36(9 Pt. 1):2973-2979.

Cruzan, G., J.R. Cushman, L.S. Andrews, G.C. Granville, R.R. Miller, C.J. Hardy, D.W. Coombs, and P.A. Mullins. 1997. Subchronic inhalation studies of styrene in CD rats and CD-1 mice. Fundam. Appl. Toxicol. 35(2):152-165.

Cummings, B.S., and L.H. Lash. 2000. Metabolism and toxicity of trichloroethylene and S(1,2-dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells. Toxicol. Sci. 53(2):458-466.

Cummings, B.S., R.C. Zangar, R.F. Novak, and L.H. Lash. 2000. Cytotoxicity of trichloroethylene and S-(1, 2-dichlorovinyl)-L-cysteine in primary cultures of rat renal proximal tubular and distal tubular cells. Toxicology 150(1-3):83-98.

Curry, S.H., P.I. Chu, T.G. Baumgartner, and P.W. Stacpoole. 1985. Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin. Pharmacol. Ther. 37(1):89-93.

Curry, S.H., A. Lorenz, P.I. Chu, M. Limacher, and P.W. Stacpoole. 1991. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Biopharm. Drug Dispos. 12(5):375-390.

Czirjak, L., and G. Kumanovic. 2002. Exposure to solvents in female patients with scleroderma. Clin. Rheumatol. 21(2):114-118.

Dallas, C.E., J.M. Gallo, R. Ramanathan, S. Muralidhara, and J.V. Bruckner. 1991. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats. Toxicol. Appl. Pharmacol. 110(2):303-314.

Damani, L.A., and A.A. Houdi. 1988. Cytochrome P-450 and FAD-monooxygenase mediated S- and N-oxygenations. Drug Metabol. Drug Interact. 6(3-4):235-244.

D’Amico, G., and C. Bazzi. 2003. Urinary protein and enzyme excretion as markers of tubular damage. Curr. Opin. Nephrol. Hypertens. 12(6):639-643.

Daniel, F.B., A.B. DeAngelo, J.A. Stober, G.R. Olson, and N.P. Page. 1992. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in male B6C3F1 mouse. Fundam. Appl. Toxicol. 19(2):159-168.

Daniel, F.B., J.R. Meier, and A.B. DeAngelo. 1993. Advances in research on carcinogenic and

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

genotoxic by-products of chlorine disinfection: Chlorinated hydroxyfuranones and chlorinated acetic acids. Ann. Ist Super Sanita 29(2):279-291.

Daniel, J.W. 1963. The metabolism of 36Cl-labeled trichloroethylene and tetrachloroethylene in the rat. Biochem. Pharmacol. 12:795-802.

Darnerud, P.O., A.L. Gustafson, U. Tornwall, and V.J. Feil. 1991. Age- and sex-dependent dichlorovinyl cysteine (DCVC) accumulation and toxicity in the mouse kidney: Relation to development of organic anion transport and beta-lyase activity. Pharmacol. Toxicol. 68(2):104-109.

Das, U.G., C.E. Cronk, S.S. Martier, P.M. Simpson, and D.G. McCarver. 2004. Alcohol dehydrogenase 2*3 affects alterations in offspring facial morphology associated with maternal ethanol intake in pregnancy. Alcohol Clin. Exp. Res. 28(10):1598-1606.

Davidson, I.W., and R.P. Beliles. 1991. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab. Rev. 23(5-6):493-599.

Dawson, B.V., P.D. Johnson, S.J. Goldberg, and J.B. Ulreich. 1990. Cardiac teratogenesis of trichloroethylene in a mammalian model. J. Am. Coll. Cardiol. 16(5):1304-1309.

Dawson, B.V., P.D. Johnson, S.J. Goldberg, and J.B. Ulreich. 1993. Cardiac teratogenesis of halogenated hydrocarbon-contaminated drinking water. J. Am. Coll. Cardiol. 21(6):1466-1472.

Deane, M., S.H. Swan, J.A. Harris, D.M. Epstein, and R.R. Neutra. 1989. Adverse pregnancy outcomes in relation to water contamination, Santa Clara County, California, 1980-1981. Am. J. Epidemiol. 129(5):894-904.

DeAngelo, A.B., F.B. Daniel, L. McMillan, P. Wernsing, and R.E. Savage, Jr. 1989. Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol. Appl. Pharmacol. 101(2):285-298.

DeAngelo, A.B., F.B. Daniel, J.A. Stober, and G.R. Olson. 1991. The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 16(2):337-347.

DeAngelo, A.B., F.B. Daniel, B.M. Most, and G.R. Olson. 1996. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology 114(3):207-221.

DeAngelo, A.B., F.B. Daniel, B.M. Most, and G.R. Olson. 1997. Failure of monochloroacetic acid and trichloroacetic acid administered in the drinking water to produce liver cancer in male F344/N rats. J. Toxicol. Environ. Health 52(5):425-445.

DeAngelo, A.B., M.H. George, and D.E. House. 1999. Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: Dose-response determination and modes of action. J. Toxicol. Environ. Health 58(8):485-507.

de Duve, C. 1969. The peroxisome: A new cytoplasmic organelle. Proc. R Soc. Lond. B Biol. Sci. 173(30):71-83.

DeGroot, M.H. 1989. Probability and Statiscs, 2nd Ed. Reading, MA: Addison-Wesley.

De Jong, P.E., and B.M. Brenner. 2004. From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria. Kidney Int. 66(6):2109-2118.

Dekant, W. 1986. Metabolic conversion of tri- and tetrachloroethylene: Formation and deactivation of genotoxic intermediates. Dev. Toxicol. Environ. Sci. 12:211-221.

Dekant, W., M. Metzler, and D. Henschler. 1984. Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans. Biochem. Pharmacol. 33(13):2021-2027.

Dekant, W., A. Schulz, M. Metzler, and D. Henschler. 1986a. Absorption, elimination and metabolism of trichloroethylene: A quantitative comparison between rats and mice. Xenobiotica 16(2):143-152.

Dekant, W., M. Metzler, and D. Henschler. 1986b. Identification of S-1,2,2-trichlorovinyl-Nacetylcysteine as a urinary metabolite of tetrachloroethylene: Bioactivation through glu-

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

tathione conjugation as a possible explanation of its nephrocarcinogenicity. J. Biochem. Toxicol. 1(2):57-72.

Dekant, W., G. Martens, S. Vamvakas, M. Metzler, and D. Henschler. 1987. Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450 dependent phospholipid alkylation. Drug Metab. Dispos. 15(5):702-709.

Dekant, W., K. Berthold, S. Vamvakas, D. Henschler, and M.W. Anders. 1988. Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2trichlorovinyl)-L-cysteine formed by cysteine conjugate beta-lyase. Chem. Res. Toxicol. 1(3):175-178.

Dekant, W., G. Urban, C. Görsmann, and M.W. Anders. 1991. Thioketene formation from a-haloalkenyl 2-nitrophenyl disulfides: Models for biological reactive intermediates of cytotoxic S-conjugates. J. Am. Chem. Soc. 113(13):5120-5122.

DerSimonian, R., and N. Laird. 1986. Meta-analysis in clinical trials. Control Clin. Trials 7(3):177-188.

Dewailly, E., S. Bruneau, P. Ayotte, C. Laliberte, S. Gingras, D. Belanger, and L. Ferron. 1993. Health status at birth of Inuit newborn prenatally exposed to organochlorines. Chemosphere 27(1-3):359-366.

DHS (California Department of Health Services). 1986. Organic Chemical Contamination of Large Public Water Systems in California. Berkeley, CA: California Department of Health Services, Sanitary Engineering Branch.

Dobrev, I.D., M.E. Andersen, and R.S. Yang. 2001. Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling. Arch. Toxicol. 75(3):134-144.

Dobrev, I.D., M.E. Andersen, and R.S. Yang. 2002. In silico toxicology: Simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane. Environ. Health Perspect. 110(10):1031-1039.

Dobson, A.J. 1990. An Introduction to Generalize Linear Models, 1st Ed. London: Chapman and Hall.

Dorfmueller, M.A., S.P. Henne, R.G. York, R.L. Bornschein, and J.M. Manson. 1979. Evaluation of teratogenicity and behavioral toxicity with inhalation exposure of maternal rats to trichloroethylene. Toxicology 14(2):153-166.

Dorne, J.L. 2004. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation. Fundam. Clin. Pharmacol. 18(6):609-620.

Dosemeci, M., S. Wacholder, and J.H. Lubin. 1990. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am. J. Epidemiol. 132(4):746-748.

Dosemeci, M., P. Cocco, M. Gomez, P.A. Stewart, and E.F. Heineman. 1994. Effects of three features of a job-exposure matrix on risk estimates. Epidemiology 5(1):124-127.

Dosemeci, M., P. Cocco, and W.H. Chow. 1999. Gender differences in risk of renal cell carcinoma and occupational exposures to chlorinated aliphatic hydrocarbons. Am. J. Ind. Med. 36(1):54-59.

Dow, J.L., and T. Green. 2000. Trichloroethylene induced vitamin B(12) and folate deficiency leads to increased formic acid excretion in the rat. Toxicology 146(2-3):123-136.

Dowsley, T.F., J.B. Ulreich, J.L. Bolton, S.S. Park, and P.G. Forkert. 1996. CYP2E1-dependent bioactivation of 1,1-dichloroethylene in murine lung: Formation of reactive intermediates and glutathione conjugates. Toxicol. Appl. Pharmacol. 139(1):42-48.

Drake, V.J., S.L. Koprowski, J. Lough, N. Hu, and S.M. Smith. 2006. Trichloroethylene exposure during cardiac valvuloseptal morphogenesis alters cushion formation and cardiac hemodynamics in the avian embryo. Environ. Health Perspect. 114(6):842-847.

Driscoll, T.R., H.H. Hamdan, G. Wang, P.F. Wright, and N.H. Stacey. 1992. Concentrations

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

of individual serum or plasma bile acids in workers exposed to chlorinated aliphatic hydrocarbons. Br. J. Ind. Med. 49(10):700-705.

D’Souza, R.W., J.V. Bruckner, and S. Feldman. 1985. Oral and intravenous trichloroethylene pharmacokinetics in the rat. J. Toxicol. Environ. Health 15(5):587-601.

Duffel, M.W., and W.B. Jakoby. 1982. Cysteine S-conjugate /V-acetyltransferase from rat kidney microsomes. Mol. Pharmacol. 21(2):444-448.

Dugard, P.H. 2000. Letter to the Editor: re: paper by Boyer et al., 2000. Toxicol. Sci. 56(2):437-438.

Dunson, D.B., C. Holloman, C. Calder, and L.H. Gunn. 2004. Bayesian modeling of multiple lesion onset and growth from interval-censored data. Biometrics 60(3):676-683.

Duricic, J., and Z. Duricic. 1991. Morphologic changes in the lung and liver parenchyma in pregnant female rats treated with petroleum and trichloroethylene [in Croatian]. Med. Arh. 45(1-2):23-25.

DuTeaux, S.B., D.E. DeGroot, and M.G. Miller. 2002. Metabolizing enzymes in the rat epididymis and efferent ducts: Potential role in male reproductive toxicology [abstract 1835]. Toxicologist 66(1-S):375.

DuTeaux, S.B., M.J. Hengel, D.E. DeGroot, K.A. Jelks, and M.G. Miller. 2003. Evidence for trichloroethylene bioactivation and adduct formation in the rat epididymis and efferent ducts. Biol. Reprod. 69(3):771-779.

DuTeaux, S.B., T. Berger, R.A. Hess, B.L. Sartini, and M.G. Miller. 2004. Male reproductive toxicity of trichloroethylene: Sperm protein oxidation and decreased fertilizing ability. Biol. Reprod. 70(5):1518-1526.

Elcombe, C.R., M.S. Rose, and I.S. Pratt. 1985. Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: Possible relevance to species differences in hepatocarcinogenicity. Toxicol. Appl. Pharmacol. 79(3):365-376.

Elfarra, A.A., and M.W. Anders. 1984. Renal processing of glutathione conjugates: Role in nephrotoxicity. Biochem. Pharmacol. 33(23):3729-3732.

Elfarra, A.A., I. Jakobson, and M.W. Anders. 1986. Mechanism of S-(1,2-dichlorovinyl)gluta thione-induced nephrotoxicity. Biochem. Pharmacol. 35(2):283-288.

Elfarra, A.A., R.J. Krause, L.R. Last, L.H. Lash, and J.C. Parker. 1998. Species-and sex-related differences in metabolism of trichloroethylene to yield chloral and trichloroethanol in mouse, rat, and human liver microsomes. Drug Metab. Dispos. 26(8):779-785.

EPA (U.S. Environmental Protection Agency). 1987. The Total Exposure Assessment Methodology (TEAM) Study: Summary and Analysis: Vol. I. EPA/600/6-87/002a. Office of Acid Deposition, Environmental Monitoring and Quality Assurance, U.S. Environmental Protection Agency, Washington, DC. June.

EPA (U.S. Environmental Protection Agency). 1991. Report of the EPA Peer Review Workshop on Alpha 2m-globulin: Association with Renal Toxicity and Neoplasia in the Male Rat. EPA/625/3-91/021. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC [online]. Available: http://cfpub.epa.gov/ncea/raf/recordisplay.cfm?deid=47531 [accessed March 10, 2006].

EPA (U.S. Environmental Protection Agency). 1994a. Final Draft Drinking Water Health Criteria Document on Chlorinated Acetic Acids, Alcohols, Aldehydes, and Ketones. PB94-179918. Office of Water, U.S. Environmental Protection Agency, Washington, DC. March 1994.

EPA (U.S. Environmental Protection Agency). 1994b. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8-90/066F. Office of Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Washington DC [online]. Available: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=71993 [accessed March 15, 2006].

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

EPA (U.S. Environmental Protection Agency). 1996. Environmental Health Treats to Children. EPA 175-F-96-001. Office of The Administrator, U.S. Environmental Protection Agency, Washington, DC. September 1996.

EPA (U.S. Environmental Protection Agency). 2001a. Sources, Emission and Exposure for Trichloroethylene (TCE) and Related Chemicals. EPA/600/R-00/099. National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC. March 2001 [online]. Available: http://www.epa.gov/ncea/pdfs/tce/TCEMarch2001.pdf [accessed March 2, 2006].

EPA (U.S. Environmental Protection Agency). 2001b. Trichloroethylene Health Risk Assessment: Synthesis and Characterization. External Review Draft. EPA/600/P-01/002A. Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC. August 2001.

EPA (U.S. Environmental Protection Agency). 2004. An Examination of EPA Risk Assessment Principles and Practices. Staff Paper Prepared for the U.S. Environmental Protection Agency by Members of the Risk Assessment Task Force. EPA/100/B-04/001. Office of the Science Advisor, U.S. Environmental Protection, Washington, DC. March 2004 [online]. Available: http://www.epa.gov/osa/ratf.htm [accessed March 16, 2006].

EPA (U.S. Environmental Protection Agency). 2005a. Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC. March 2005.

EPA (U.S. Environmental Protection Agency). 2005b. Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens. EPA/630/R-03/003F. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC. March 2005 [online]. Available: http://www.epa.gov/iris/children032505.pdf [accessed June 1, 2006].

Epstein, D.L., G.A. Nolen, J.L. Randall, S.A. Christ, E.J. Read, J.A. Stober, and M.K. Smith. 1992. Cardiopathic effects of dichloroacetate in the fetal Long-Evans rat. Teratology 46(3):225-235.

Eskenazi, B., M.B. Bracken, T.R. Holford, and J. Grady. 1988. Exposure to organic solvents and hypertensive disorders of pregnancy. Am. J. Ind. Med. 14(2):177-188.

Estonius, M., S. Svensson, and J.O. Hoog. 1996. Alcohol dehydrogenase in human tissues: Localisation of transcripts coding for five classes of the enzyme. FEBS Lett. 397(2-3):338-342.

Everhart, J.L., D.T. Kurtz, and J.M. McMillan. 1998. Dichloroacetic acid induction of peroxisome proliferation in cultured hepatocytes. J. Biochem. Mol. Toxicol. 12(6):351-359.

Eyre, R.J., D.K. Stevens, J.C. Parker, and R.J. Bull. 1995a. Acid-labile adducts to protein can be used as indicators of the cysteine S-conjugate pathway of trichloroethylene metabolism. J. Toxicol. Environ. Health 46(4):443-464.

Eyre, R.J., D.K. Stevens, J.C. Parker, and R.J. Bull. 1995b. Renal activation of trichloroethylene and S-(1,2-dichlorovinyl-cysteine and cell proliferative responses in the kidneys of F344 rats and B6C3F1 mice. J. Toxicol. Environ. Health 46(4):465-481.

Fairbrother, K.S., J. Grove, I. de Waziers, D.T. Steimel, C.P. Day, C.L. Crespi, and A.K. Daly. 1998. Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 8(6):543-552.

Faustman, E.M., and S.M. Bartell. 1997. Review of noncancer risk assessment: Applications of benchmark dose methods. Human Ecol. Risk Assess. 3(5):893-920.

Fawer, C.L., A. Torrado, and J.P. Guignard. 1979. Maturation of renal function in full-term and premature neonates. Helv. Paediatr. Acta 34(1):11-21.

Feldman, R.G., R.F. White, J.M. Currie, P.H. Travers, and S. Lessell. 1985. Long-term followup after single toxic exposure to trichloroethylene. Am. J. Ind. Med. 8(2):119-126.

Ferlay, J., F. Bray, P. Pisani, and D.M. Parkin. 2004. GLOBOCAN 2002: Cancer Incidence,

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Mortality and Prevalence Worldwide. IARC CancerBase No. 5, Version 2.0. Lyon, France: IARC Press.

Ferreira-Gonzalez, A., A.B. DeAngelo, S. Nasim, and C.T. Garrett. 1995. Ras oncogene activation during hepatocarcinogenesis in B6C3F1 male mice by dichloroacetic and trichloroacetic acids. Carcinogenesis 16(3):495-500.

Ferson, S. 1996. What Monte Carlo methods cannot do. Hum. Ecol. Risk Assess. 2(4): 990-1007.

Fisher, D.M., C. O’Keeffe, D.R. Stanski, R. Cronnelly, R.D. Miller, and G.A. Gregory. 1982. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 57(3):203-208.

Fisher, J.W. 2000. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites. Environ. Health Perspect. 108(Suppl. 2):265-273.

Fisher, J.W., T.A. Whittaker, D.H. Taylor, H.J. Clewell, III, and M.E.Andersen. 1989. Physiologically-based pharmacokinetic modeling ol the pregnant rat: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Phamacol. 99(3):395-414.

Fisher, J.W., M.L. Gargas, B.C. Allen, and M.E. Andersen. 1991. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. Toxicol. Appl. Pharmacol. 109(2):183-195.

Fisher, J.W., D.A. Mahle, and R. Abbas. 1998. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol. Appl. Pharmacol. 152(2):339-359.

Fisher, J., P. Todd, D. Mattie, D. Godfrey, L. Narayanan, and K. Yu. 2000. Preliminary development of a physiological model for perchlorate in the adult male rat: A framework for further studies. Drug Chem. Toxicol. 23(1):243-258.

Fisher, J.W., S.R. Channel, J.S. Eggers, P.D. Johnson, K.L. MacMahon, C.D. Goodyear, G.L. Sudberry, D.A. Warren, J.R. Latendresse, and L.J. Graeter. 2001. Trichlorethylene, trichloroacetic acid, and dichloroacetic acid: Do they affect fetal rat heart development? Int. J. Toxicol. 20(5):257-267.

Flegal, K.M., M.D. Carroll, C.L. Ogden, and C.L. Johnson. 2002. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288(14):1723-1727.

Forkert, P.G. 1995. CYP2E1 is preferentially expressed in Clara cells of murine lung: Localization by in situ hybridization and immunohistochemical methods. Am. J. Respir. Cell Mol. Biol. 12(6):589-596.

Forkert, P.G. 1999. In vivo formation and localization of 1,1-dichloroethylene epoxide in murine liver: Identification of its glutathione conjugate 2-S-glutathionyl acetate. J. Pharmacol. Exp. Ther. 290(3):1299-1306.

Forkert, P.G., and D.W. Birch. 1989. Pulmonary toxicity of trichloroethylene in mice. Covalent binding and morphological manifestations. Drug Metab. Dispos. 17(1):106-113.

Forkert, P.G., and L. Forkert. 1994. Trichloroethylene induces pulmonary fibrosis in mice. Can. J. Physiol. Phamacol. 72(3):205-210.

Forkert, P.G., P.L. Sylvestre, and J.S. Poland. 1985. Lung injury induced by trichloroethylene. Toxicology 35(2):143-160.

Forkert, P.G., A.M. Malkinson, P. Rice, and M. Moussa. 1999. Diminished CYP2E1 expression and formation of 2-S-glutathionyl acetate, a glutathione conjugate derived from 1,1-dichloroethylene epoxide, in murine lung tumors. Drug Metab. Dispos. 27(1):68-73.

Forkert, P.G., R.P. Lee, and K. Reid. 2001. Involvement of CYP2E1 and carboxylesterase enzymes in vinyl carbamate metabolism in human lung microsomes. Drug Metab. Dispos. 29:258-263.

Forkert, P.G., L.H. Lash, V. Nadeau, R. Tardif, and A. Simmonds. 2002. Metabolism

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

and toxicity of trichloroethylene in epididymis and testis. Toxicol. Appl. Pharmacol. 182(3):244-254.

Forkert, P.G., L. Lash, R. Tardif, N. Tanphaichitr, C. Vandevoort, and M. Moussa. 2003. Identification of trichloroethylene and its metabolites in human seminal fluid of workers exposed to trichloroethylene. Drug Metab. Dispos. 31(3):306-311.

Forkert, P.G., R.M. Baldwin, B. Millen, L.H. Lash, D.A. Putt, M.A. Shultz, and K.S. Collins. 2005. Pulmonary bioactivation of trichloroethylene to chloral hydrate: Relative contributions of CYP2E1, CYP2F, and CYP2B1. Drug Metab. Dispos. 33(10):1429-1437.

Forkert, P.G., B. Millen, L.H. Lash, D.A. Putt, and B.I. Ghanayem. 2006. Pulmonary bronchiolar cytotoxicity and formation of dichloroacetyl lysine protein adducts in mice treated with trichloroethylene. J. Pharmacol. Exp. Ther. 316(2):520-529.

Fort, D.J., J.R. Rayburn, D.J. DeYoung, and J.A. Bantle. 1991. Assessing the efficacy of an Anochlor 1254-induced exogenous metabolic activation system for FETAX. Drug Chem. Toxicol. 14(1-2):143-160.

Fort, D.J., E.L. Stover, J.R. Rayburn, M. Hull, and J.A. Bantle. 1993. Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus. Teratol. Carcinog. Mutagen. 13(1):35-45.

Fox, A.J., and P.F. Collier. 1976. Low mortality rates in industrial cohort studies due to selection for work and survival in the industry. Br. J. Prev. Soc. Med. 30(4):225-230.

Fox, A.W., B.W. Sullivan, J.D. Buffini, M.L. Neichin, R. Nicora, F.K. Hoehler, R. O’Rourke, and R.R. Stoltz. 1996. Reduction of serum lactate by sodium dichloroacetate, and human pharmacokinetic-pharmacodynamic relationships. J. Pharmacol. Exp. Ther. 279(2):686-693.

Fox, S.H., T.D. Koepsell, and J.R. Daling. 1994. Birth weight and smoking during pregnancy— effect modification by maternal age. Am. J. Epidemiol. 139(10):1008-1015.

Franco, G., R. Fonte, G. Tempini, and F. Candura. 1986. Serum bile acid concentrations as a liver function test in workers occupationally exposed to organic solvents. Int. Arch. Occup. Environ. Health 58(2):157-164.

Frick, M.H., O. Elo, K. Haapa, O.P. Heinonen, P. Heinsalmi, P. Helo, J.K. Huttunen, P. Kaitaniemi, P. Koskinen, V. Manninen, H. Mäenpää, M. Mälkönen, M. Mänttäri, S. Norola, A. Pasternack, J. Pikkarainen, M. Romo, T. Sjöblom, and E.A. Nikkilä. 1987. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med. 317(20):1237-1245.

Friedman, P.J., and J.R. Cooper. 1960. The role of alcohol dehydrogenase in the metabolism of chloral hydrate. J. Pharmacol. Exp. Ther. 129:373-376.

Fukuda, K., K. Takemoto, and H. Tsuruta. 1983. Inhalation carcinogenicity of trichloroethylene in mice and rats. Ind. Health 21(4):243-254.

Gandolfi, A.J., R.B. Nagle, J.J. Soltis, and F.H. Plescia. 1981. Nephrotoxicity of halogenated vinyl cysteine compounds. Res. Commun. Chem. Pathol. Pharmacol. 33(2):249-261.

Garabrant, D.H., and C. Dumas. 2000. Epidemiology of organic solvents and connective tissue disease. Arthritis Res. 2(1):5-15.

Garabrant, D.H., J. Held, B. Langholz, and L. Bernstein. 1988. Mortality of aircraft manufacturing workers in southern California. Am. J. Ind. Med. 13(6):683-693.

Garabrant, D.H., J.V. Lacey, Jr., T.J. Laing, B.W. Gillespie, M.D. Mayes, B.C. Cooper, and D. Schottenfeld. 2003. Scleroderma and solvent exposure among women. Am. J. Epidemiol. 157(6):493-500.

Gardner, H.S., Jr., L.M. Brennan, M.W. Toussaint, A.B. Rosencrance, E.M. Boncavage-Hennessey, and M.J. Wolfe. 1998. Environmental complex mixture toxicity assessment. Environ. Health Perspect. 106(Suppl. 6):1299-1305.

Garshick, E., M.B. Schenker, A. Munoz, M. Segal, T.J. Smith, S.R. Woskie, S.K. Hammond,

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

and F.E. Speizer. 1987. A case-control study of lung cancer and diesel exhaust exposure in railroad workers. Am. Rev. Resp. Dis. 135(6):1242-1248.

Ge, R., S. Yang, P.M. Kramer, L. Tao, and M.A. Pereira. 2001. The effect of dichloroacetic acid and trichloroacetic acid on DNA methylation and cell proliferation in B6C3F1 mice. J. Biochem. Mol. Toxicol. 15(2):100-106.

Gelfand, A.E., and A.F.M. Smith. 1990. Sampling based approaches to calculating marginal densities. J. Am. Stat. Assoc. 85(410):398-409.

Gelman, A., J.B. Carlin, H.S. Stern, and D.B Rubin. 1995. Bayesian Data Analysis. New York: Chapman and Hall.

Gelman, A., F. Bois, and J. Jiang. 1996. Physiological pharmacokinetic analysis using population modeling and informative prior distributions. J. Am. Stat. Assoc. 91(436): 1400-1412.

Gelman, A., J.B. Carlin, H.S. Stern, and D.B. Rubin. 2004. Bayesian Data Analysis, 2nd Ed. Boca Raton, FL: Chapman & Hall.

Gelman, L., J.C. Fruchart, and J. Auwerx. 1999. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer. Cell Mol. Life Sci. 55(6-7):932-943.

Gentry, P.R., C.E. Hack, L. Haber, A. Maier, and H.J. Clewell, III. 2002. An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: Examples with warfarin and parathion. Toxicol. Sci. 70(1):120-139.

George, M.H., T. Moore, S. Kilburn, G.R. Olson, and A.B. DeAngelo. 2000. Carcinogenicity of chloral hydrate administered in drinking water to the male F344/N rat and male B6C3F1 mouse. Toxicol. Pathol. 28(4):610-618.

Gerde, P, B.A. Muggenburg, and R.F. Henderson. 1993. Disposition of polycyclic aromatic hydrocarbons in the respiratory tract of the beagle dog. III. Mechanisms of the dosimetry. Toxicol. Appl. Pharmacol. 121(2):328-334.

Gerlach, M., A.Y. Xiao, C. Heim, J. Lan, R. God, D. Feineis, G. Bringmann, P. Riederer, and K.H. Sontag. 1998. 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats. Neurosci. Lett. 257(1):17-20.

Ghantous, H., B.R. Danielsson, L. Dencker, J. Gorzak, and O. Vesterberg. 1986. Trichloroacetic acid accumulates in murine amniotic fluid after tri- and tetrachloroethylene inhalation. Acta Pharmacol. Toxicol. 58(2):105-114.

Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd Ed. New York: Marcel Dekker.

Gilbert, K.M., J.M. Griffin, and N.R. Pumford. 1999. Trichloroethylene activates CD4+T cells: Potential role in an autoimmune response. Drug Metab. Rev. 31(4):901-916.

Gilbert, K.M., A.B. Whitlow, and N.R. Pumford. 2004. Environmental contaminant and disinfection by-product trichloroacetaldehyde stimulates T cells in vitro. Int. Immunopharmacol. 4(1):25-36.

Gilkeson, G.S., D. Keil, and M. Peden-Adams. 2004. Immune effects of trichloroethylene on autoimmune disease in mice. Pp. 87-98 in Trichloroethylene: The Scientific Basis of Risk Assessment, L.C. Mohr, D.G. Hoel, and D. Jollow, eds. Charleston, SC: The Medical University of South Carolina Press.

Gilks, W., S. Richardson, and D. Spiegelhalter. 1996. Markov Chain Monte Carlo in Practice. London: Chapman and Hall.

Ginsberg, G., S. Smolenski, D. Hattis, and B. Sonawane. 2002. Population distribution of aldehyde dehydrogenase-2 genetic polymorphism: Implications for risk assessment. Regul. Toxicol. Pharmacol. 36(3):297-309.

Ginsberg, G., W. Slikker, Jr., J. Bruckner, and B. Sonawane. 2004a. Incorporating children’s toxicokinetics into a risk framework. Environ. Health Perspect. 112(2):272-283.

Ginsberg, G., D. Hattis, A. Russ, and B. Sonawane. 2004b. Physiologically based pharmacoki-

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

netic (PBPK) modeling of caffeine and theophylline in neonates and adults: Implications for assessing children’s risks from environmental agents. J. Toxicol. Environ. Health A 67(4):297-329.

Giovanetti, A., L. Rossi, M. Mancuso, C.C. Lombardi, M.R. Marasco, F. Manna, P. Altavista, and E.M. Massa. 1998. Analysis of lung damage induced by trichloroethylene inhalation in mice fed diets with low, normal, and high copper content. Toxicol. Pathol. 26(5):628-635.

Gnarra, J.R., K. Tory, Y. Weng, L. Schmidt, M.H. Wei, H. Li, F. Latif, S. Liu, F. Chen, F.M. Duh, I. Lubensky, D.R. Duan, C. Florence, R. Pozzatti, M.M. Walther, N.H. Bander, H.B. Grossman, H. Brauch, S. Pomer, J.D. Brooks, W.B. Isaacs, M.I. Lerman, B. Zbar, and W.M. Linehan. 1994. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet. 7(1):85-90.

Gnarra, J.R., J.M. Ward, F.D. Porter, J.R. Wagner, D.E. Devor, A. Grinberg, M.R. EmmertBuck, H. Westphal, R.D. Klausner, and W.M. Linehan. 1997. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc. Natl. Acad. Sci. USA 94(17):9102-9107.

Goh, V.H., S.E. Chia, and C.N. Ong. 1998. Effects of chronic exposure to low doses of trichloroethylene on steroid hormone and insulin levels in normal men. Environ. Health Perspect. 106(1):41-44.

Gold, L.S., and T.H. Slone. 1995. The mouse liver in perpsective: Comparison of target organs of carcinogenicity for mutagens and non-mutagens in chronic bioassay. Fifth Workshop on Mouse Liver Tumors: Summary Report. Washington, DC: International Life Sciences Institute.

Goldberg, M.E., H.E. Johnson, U.C. Pozzani, and H.F. Smyth, Jr. 1964. Effects of repeated inhalation of vapors of industrial solvents on animal behavior. I. Evaluation of nine solvent vapors on pole-climb performance in rats. Am. Ind. Hyg. Assoc. J. 25:369-375.

Goldberg, M.S., M.E. Parent, J. Siemiatycki, M. Desy, L. Nadon, L. Richardson, R. Lakhani, B. Latreille, and M.F. Valois. 2001. A case-control study of the relationship between the risk of colon cancer in men and exposures to occupational agents. Am. J. Ind. Med. 39(6):531-546.

Goldberg, S.J., M.D. Lebowitz, E.J. Graver, and S. Hicks. 1990. An association of human congenital cardiac malformations and drinking water contaminants. J. Am. Coll. Cardiol. 16(1):155-164.

Goldsworthy, T.L., and J.A. Popp. 1987. Chlorinated hydrocarbon-induced peroxisomal enzyme activity in relation to species and organ carcinogenicity. Toxicol. Appl. Pharmacol. 88(2):225-233.

Goldsworthy, T.L., O. Lyght, V.L. Burnett, and J.A. Popp. 1988. Potential role of alpha-2 muglobulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethane. Toxicol. Appl. Pharmacol. 96(2):367-379.

Gonzalez, F.J., J.M. Peters, and R.C. Cattley. 1998. Mechanism of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferators-activator receptor alpha. J. Nat. Cancer Inst. 90(22):1702-1709.

Gonzalez-Leon, A., I.R. Schultz, G. Xu, and R.J. Bull. 1997. Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water. Toxicol. Appl. Pharmacol. 146(2):189-195.

Gonzalez-Leon, A., J.L. Merdink, R.J. Bull, and I.R. Schultz. 1999. Effect of pretreatment with dichloroacetic or trichloroacetic acid in drinking water on the pharmacokinetics of a subsequent challenge dose in B6C3F1 mice. Chem. Biol. Interact. 123(3):239–253.

Gorsky, L.D., D.R. Koop, and M.J. Coon. 1984. On the stoichiometry of the oxidase and

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reduction. J. Biol. Chem. 259(11):6812-6817.

Grasl-Kraupp, B., T. Waldhor, W. Huber, and R. Schulte-Hermann. 1993. Glutathione Stransferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis 14(11):2407-2412.

Green, L.C., and T.L. Lash. 1999. Re: “Renal cell cancer correlated with occupational exposure to trichloroethylene.” J. Cancer Res. Clin. Oncol. 125(7):430-432.

Green, S. 1992. Peroxisome proliferators: A model for receptor mediated carcinogenesis. Cancer Surv. 14:221-232.

Green, S. 1995. PPAR: A mediator of peroxisome proliferator action. Mutat. Res. 333(1-2): 101-109.

Green, S., and W. Wahli. 1994. Peroxisome proliferator-activated receptors: Finding the orphan a home. Mol. Cell Endocrinol. 100(1-2):149-153.

Green, T. 1990. Chloroethylenes: A mechanistic approach to human risk evaluation. Ann. Rev. Pharmacol. Toxicol. 30:73-89.

Green, T. 2000. The pulmonary toxicity and carcinogenicity of trichloroethylene: Species differences and modes of action. Environ. Health Perspect. 108(Suppl. 2):261-264.

Green, T., and M.S. Prout. 1985. Species differences in response to trichloroethylene. II. Biotransformation in rats and mice. Toxicol. Appl. Pharmacol. 79(3):401-411.

Green, T., J. Odum, J.A. Nash, and J.R. Foster. 1990. Perchloroethylene-induced rat kidney tumors: An investigation of the mechanisms involved and their relevance to humans. Toxicol. Appl. Pharmacol. 103(1):77-89.

Green, T., J. Dow, M.K. Ellis, J.R. Foster, and J. Odum. 1997a. The role of glutathione conjugation in the development of kidney tumors in rats exposed to trichloroethylene. Chem. Biol. Interact. 105(2):99-117.

Green, T., G.W. Mainwaring, and J.R. Foster. 1997b. Trichloroethylene induced lung tumors: Studies of the mode of action and comparisons between species. Fundam. Appl. Toxicol. 37(2):125-130.

Green, T., J. Dow, J.R. Foster, and P.M. Hext. 1998. Formic acid excretion in rats exposed to trichloroethylene: A possible explanation for renal toxicity in long-term studies. Toxicology 127(1-3):39-47.

Green, T., J. Dow, and J. Foster. 2003. Increased formic acid excretion and the development of kidney toxicity in rats following chronic dosing with trichloroethanol, a major metabolite of trichloroethylene. Toxicology 191(2-3):109-119.

Green, T., J. Dow, C.N. Ong, V. Ng, H.Y. Ong, Z.X. Zhuang, X.F. Yang, and L. Bloemen. 2004. Biological monitoring of kidney function among workers occupationally exposed to trichloroethylene. Occup. Environ. Med. 61(4):312-317.

Greenland, S. 1987. Quantitative methods in the review of epidemiologic literature. Epidemiol. Rev. 9:1-30.

Greenland, S. 2001. Sensitivity analysis, Monte Carlo risk analysis, and Bayesian uncertainty assessment. Risk Anal. 21(4):579-583.

Greenland, S., and J. Robins. 1994. Invited commentary: Ecologic studies—biases, misconceptions, and counterexamples. Am. J. Epidemiol. 139(8):747-760.

Greenland, S., A. Salvan, D.H. Wegman, M.F. Hallock, and T.J. Smith. 1994. A case-control study of cancer mortality at a transformer assembly facility. Int. Arch. Occup. Environ. Health 66(1):49-54.

Griffin, J.M., K.M. Gilbert, L.W. Lamps, and N.R. Pumford. 2000a. CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol. Sci. 57(2):345-352.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Griffin, J.M., K.M. Gilbert, and N.R. Pumford. 2000b. Inhibition of CYP2E1 reverses CD4+ Tcell alterations in trichloroethylene-treated MRL+/+ mice. Toxicol. Sci. 54(2):384-389.

Griffin, J.M., S.J. Blossom, S.K. Jackson, K.M. Gilbert, and N.R. Pumford. 2000c. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 46(2):123-137.

Guan, Y. 2002. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease. Minerva Urol. Nefrol. 54(2):65-79.

Guehl, D., E. Bezard, S. Dovero, T. Boraud, B. Bioulac, and C. Gross. 1999. Tirchloroethylene and parkinsonism: A human and experimental observation. Eur. J. Neurol. 6(5):609-611.

Guengerich, F.P., and T. Shimada. 1991. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4(4):391-407.

Guengerich, F.P., D.H. Kim, and M. Iwasaki. 1991. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4(2):168-179.

Haario, H., M. Laine, M. Lehtinen, E. Saksman, and J. Tamminen. 2004. Markov chain Monte Carlo methods for high dimensional inversion in remote sensing. J. R. Statist. Soc. B 66(3):591-607, 648-649.

Haase, V.H., J.N. Glickman, M. Socolovsky, and R. Jaenisch. 2001. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. USA 98(4):1583-1588.

Hack, C.E., W.A. Chiu, Q.J. Zhao, and H.J. Clewell. 2006. Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites. Regul. Toxicol. Pharmacol. 46(1):63-83.

Haddad, S., G. Charest-Tardif, and K. Krishnan. 2000. Physiologically based modeling of the maximal effect of metabolic interactions on the kinetics of components of complex chemical mixtures. J. Toxicol. Environ. Health Part A 61(3):209-223.

Haddad, S., C. Restieri, and K. Krishnan. 2001. Characterization of age-related changes in body weight and organ weights from birth to adolescence in humans. J. Toxicol. Environ. Health A 64(6):453-464.

Haglid, K.G., C. Briving, H.A. Hansson, L. Rosengren, P. Kjellstrand, D. Stavron, U. Swedin, and A. Wronski. 1981. Trichloroethylene: Long-lasting changes in the brain after rehabilitation. Neurotoxicology 2(4):659-673.

Han, W.K., and J.V. Bonventre. 2004. Biologic markers for the early detection of acute kidney injury. Curr. Opin. Crit. Care 10(6):476-482.

Hanasono, G.K., H. Witschi, and G.L. Plaa. 1975. Potentiation of the hepatotoxic responses to chemicals in alloxan-diabetic rats. Proc. Soc. Exp. Biol. Med. 149(4):903-907.

Hansen, J., O. Raaschou-Nielsen, J.M. Christensen, I. Johansen, J.K. McLaughlin, L. Lipworth, W.J. Blot, and J.H. Olsen. 2001. Cancer incidence among Danish workers exposed to trichloroethylene. J. Occup. Environ. Med. 43(2):133-139.

Hardell, L., N.O. Bengtsson, U. Jonsson, S. Eriksson, and L.G. Larsson. 1984. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria—an epidemiological investigation. Br. J. Cancer 50(3):389-397.

Hardin, B.D., B.J. Kelman, and R.L. Brent. 2005. Trichloroethylene and dichloroethylene: A critical review of teratogenicity. Birth Defects Res. A Clin. Mol. Teratol. 73(12): 931-955.

Harrington, J.M., H. Whitby, C.N. Gray, F.J. Reid, T.C. Aw, and J.A. Waterhouse. 1989. Renal disease and occupational exposure to organic solvents: A case referent approach. Br. J. Ind. Med. 46(9):643-650.

Harris, M.I. 1995. Descriptive epidemiology: Classification and diagnositic criteria. Pp. 1-14 in Diabetes in America, 2nd Ed., M.I. Harris, C.C. Cowie, M.P. Stern, E.J. Boyko, G.E.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Reiber, and P.H. Bennett, eds. National Diabetes Data Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD [online]. Available: http://diabetes.niddk.nih.gov/dm/pubs/america/contents.htm [accessed March 29, 2006].

Harth, V., T. Brüning, and H.M. Bolt. 2005. Renal carcinogenicity of trichloroethylene: Update, mode of action, and fundamentals for occupational standard seetting. Rev. Environ. Health 20(2):103-118.

Hayashi, S., J. Watanabe, and K. Kawajiri. 1991. Genetic polymorphisms in the 5’-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. (Tokyo) 110(4):559-565.

Hayes, J.D., J.U. Flanagan, and J.R. Jowsey. 2005. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45:51-88.

Heimann, G. 1981. Drug disposition during the perinatal period. Int. J. Biol. Res. Pregnancy 2(1):1-14.

Heinemann, K., S.N. Willich, L.A. Heinemann, T. DoMinh, M. Mohner, and G.E. Heuchert. 2000. Occupational exposure and liver cancer in women: Results of the Multicentre International Liver Tumour Study (MILTS). Occup. Med. 50(6):422-429.

Henderson, G.N., Z. Yan, M.O. James, N. Davydova, and P.W. Stacpoole. 1997. Kinetics and metabolism of chloral hydrate in children: Identification of dichloroacetate as a metabolite. Biochem. Biophys. Res. Commun. 235(3):695-698.

Hendler, A.H., and W.L. Crow. 1992. Paper No. 92-75.05 in Proceedings of Annual 85th Meeting Air & Waste Management Association, June 21-26, 1992, Kansas City, MO. Pittsburgh: Air & Waste Management Association.

Henschler, D, W. Romen, H.M Elsasser, D. Reichert, E. Eder, and Z. Radwan. 1980. Carcinogenicity study of trichloroethylene by longterm inhalation in three animal species. Arch. Toxicol. 43(4):237-248.

Henschler, D., H. Elsasser, H. Romen, and E. Eder. 1984. Carcinogenicity study of trichloroethylene, with and without epoxide stabilizers, in mice. J. Cancer Res. Clin. Oncol. 107(3):149-156.

Henschler, D., S. Vamvakas, M. Lammert, W. Dekant, B. Kraus, B. Thomas, and K. Ulm. 1995. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethylene. Arch. Toxicol. 69(5):291-299.

Hernberg, S., T. Kauppinen, R. Riala, M.L. Korkala, and U. Asikainen. 1988. Increased risk for primary liver cancer among women exposed to solvents. Scand. J. Work Environ. Health 14(6):356-365.

Herren-Freund, S.L., M.A. Pereira, M.D. Khoury, and G. Olson. 1987. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol. Appl. Pharmacol. 90(2):183-189.

Hers, I., R. Zapf-Gilje, L. Li, and J. Atwater. 2001. The use of indoor air measurements to evaluate intrusion of subsurface VOC vapors into buildings. J. Air Waste Manage. Assoc. 51(9):1318-1331.

Hertz-Picciotto, I. 1995. Epidemiology and quantitative risk assessment: A bridge from science to policy. Am. J. Public Health 85(4):484-491.

Hiley, C., J. Bell, R. Hume, and R. Strange. 1989. Differential expression of alpha and pi isoenzymes of glutathione S-transferase in developing human kidney. Biochim. Biophys. Acta. 990(3):321-324.

Hill, B. 1965. The environment and disease: Association or causation? Proc. Royal Soc. Med. 58(May):295-300.

Hines, R.N., and D.G. McCarver. 2002. The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes. J. Pharmacol. Exp. Ther. 300(2):355-360.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Hirsch, I.A., and H.L. Zauder. 1986. Chloral hydrate: A potential cause of arrhythmias. Anesth. Analg. 65(6):691-692.

Hoar, S.K., A.S. Morrison, and D.T. Silverman. 1980. An occupation and exposure linkage system for the study of occupational carcinogenesis. J. Occup. Med. 22(11):722-726.

Hobara, T., H. Kobayashi, E. Higashihara, T. Kawamoto, and T. Sakai. 1984. Acute effects of 1,1,1-trichloroethane, trichloroethylene, and toluene on hematologic parameters in dogs. Arch. Environ. Contam. Toxicol. 13(5):589-593.

Hoel, D.G. 1980. Incorporation of background in dose-response models. Fed. Proc. 39(1): 73-75.

Hoffman, S., N. Mishima, and E.L. Krug. 2004. An improved model for evaluating trichloroethylene and its metabolites as cardiac specific teratogens. Pp. 69-79 in Trichloroethylene: The Scientific Basis of Risk Assessment, L.C. Mohr, D.G. Hoel, and D. Jollow, eds. Charleston, SC: The Medical University of South Carolina Press.

Hsieh, C.C., A.M. Walker, and S.K. Hoar. 1983. Grouping occupations according to carcinogenic potential: Occupation clusters from an exposure linkage system. Am. J. Epidemiol. 117(5):575-589.

Hu, Y., M. Oscarson, I. Johansson, Q.Y. Yue, M.L. Dahl, M. Tabone, S. Arinco, E. Albano, and M. Ingelman-Sundberg. 1997. Genetic polymorphism of human CYP2E1: Characterization of two variant alleles. Mol. Pharmacol. 51(3):370-376.

Hunter, E.S., III, E.H. Rogers, J.E. Schmid, and A. Richard. 1996. Comparative effects of haloacetic acids in whole embryo culture. Teratology 54(2):57-64.

Hustert, E., M. Haberl, O. Burk, R. Wolbold, Y.Q. He, K. Klein, A.C. Nuessler, P. Neuhaus, J. Klattig, R. Eiselt, I. Koch, A. Zibat, J. Brockmoller, J.R. Halpert, U.M. Zanger, and L. Wojnowski. 2001. The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 11(9):773-779.

Huttunen, J.K., O.P. Heinonen, V. Manninen, P. Koskinen, T. Hakulinen, L. Teppo, M. Manttari, and M.H. Frick. 1994. The Helsinki Heart Study: An 8.5-year safety and mortality follow-up. J. Intern. Med. 235(1):31-39.

IARC (International Agency for Research on Cancer). 1995a. Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 63. Lyon, France: IARC.

IARC (International Agency for Research on Cancer). 1995b. Trichloroethylene. Pp. 75-158 in Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 63. Lyon, France: IARC.

IARC (International Agency for Research on Cancer). 1996. Clofibrate. Pp. 391-426 in Some Pharmaceutical Drugs. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 66. Lyon, France: IARC.

IARC (International Agency for Research on Cancer). 2004. Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 83. Lyon, France: IARC Press.

IAS (International Atherosclerosis Society). 2005. White Paper on the Development of PPAR Agonists. Preliminary Draft, March 16, 2005. International PPAR Task Force, International Atherosclerosis Society, Milan, Italy.

Iavicoli, I., A. Marinaccio, and G. Carelli. 2005. Effects of occupational trichloroethylene exposure on cytokine levels in workers. J. Occup. Environ. Med. 47(5):453-457.

Ikeda, M., H. Ohtsuji, T. Imamura, and Y. Komoike. 1972. Urinary excretion of total trichloro-compounds, trichloroethanol, and trichloroacetic acid as a measure of exposure to trichloroethylene and tetrachloroethylene. Br. J. Ind. Med. 29(3):328-333.

Ikeda, M., Y. Miyake, M. Ogata, and S. Ohmori. 1980. Metabolism of trichloroethylene. Biochem. Pharmacol. 29(21):2983-2992.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Infante-Rivard, C., J. Siemiatycki, R. Lakhani, and L. Nadon. 2005. Maternal exposure to occupational solvents and childhood leukemia. Environ. Health Perspect. 113(6): 787-792.

Inoue, O., K. Seiji, T. Kawai, C. Jin, Y.T. Liu, Z. Chen, S.X. Cai, S.N. Yin, G.L. Li, H. Nakatsuka, T. Watanabe, and M. Ikeda. 1989. Relationship between vapor exposure and urinary metabolite excretion among workers exposed to trichloroethylene. Am. J. Ind. Med. 15(1):103-110.

IOM (Institute of Medicine). 2003. Gulf War and Health, Vol. 2, Insecticides and Solvents. Washington, DC: National Academies Press.

Irons, R.D. 1992. Benzene and other hemotoxins. Pp. 718-731 in Hazardous Materials Toxicology: Clinical Principles of Environmental Health, J.B. Sullivan, and G.R. Krieger, eds. Baltimore, MD: Williams & Wilkins.

Isaacs, K.K., M.V. Evans, and T.R. Harris. 2004. Visualization-based analysis for a mixed-inhibition binary PBPK model: Determination of inhibition mechanism. J. Pharmacokinet. Pharmacodyn. 31(3):215-242.

Isaacson, L.G., and D.H. Taylor. 1989. Maternal exposure to 1,1,2-trichloroethylene affects myelin in the hippocampal formation of the developing rat. Brain Res. 488(1-2): 403-407.

Isaacson, L.G., S.A. Spohler, and D.H. Taylor. 1990. Trichloroethylene affects learning and decreases myelin in the rat hippocampus. Neurotoxicol. Teratol. 12(4):375-381.

Itoh, T., M. Matsumoto, M. Nakamura, A. Okada, N. Shirahashi, H. Hougaku, H. Hashimoto, M. Sakaguchi, N. Handa, T. Takeshita, K. Morimoto, and M. Hori. 1997. Effects of daily alcohol intake on the blood pressure differ depending on an individual’s sensitivity to alcohol: Oriental flushing as a sign to stop drinking for health reasons. J. Hypertens. 15(11):1211-1217.

Jacobson, J.L., S.W. Jacobson, and R.J. Sokol. 1996. Increased vulnerability to alcoholrelated birth defects in the offspring of mothers over 30. Alcohol Clin. Exp. Res. 20(2):359-363.

Jacobson, J.L., S.W. Jacobson, R.J. Sokol, and J.W. Ager, Jr. 1998. Relation of maternal age and pattern of pregnancy drinking to functionally significant cognitive deficit in infancy. Alcohol Clin. Exp. Res. 22(2):345-351.

Jaeschke, H., G.J. Gores, A.I. Cederbaum, J.A. Hinson, D. Pessayre, and J.J. Lemasters. 2002. Mechanisms of hepatotoxicity. Toxicol. Sci. 65(2):166-176.

James, N.H., J.H. Gill, R. Brindle, N.J. Woodyatt, N. Macdonald, M. Rolfe, S.C. Hasmall, J.D. Tugwood, P.R. Holden, and R.A. Roberts. 1998. Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis. Toxicol. Lett. (102-103):91-96.

Jaspers, R.M., H. Muijser, J.H. Lammers, and B.M. Kulig. 1993. Mid-frequency hearing loss and reduction of acoustic startle responding in rats following trichloroethylene exposure. Neurotoxicol. Teratol. 15(6):407-412.

Jensen, O.M., J.B. Knudsen, J.K. McLaughlin, and B.L. Sorensen. 1988. The Copenhagen case-control study of renal pelvis and ureter cancer: Role of smoking and occupational exposures. Int. J. Cancer 41(4):557-561.

Jo, W.K., C.P. Weisel, and P.J. Lioy. 1990. Routes of chloroform exposure and body burden from showering with chlorinated tap water. Risk Anal. 10(4):575-580.

Johnson, P.D., B.V. Dawson, and S.J. Goldberg. 1998a. Cardiac teratogenicity of trichloroethylene metabolites. J. Am. Coll. Cardiol. 32(2):540-545.

Johnson, P.D., B.V. Dawson, and S.J. Goldberg. 1998b. A review: Trichloroethylene metabolites: Potential cardiac teratogens. Environ. Health Perspect. 106(Suppl. 4):995-999.

Johnson, P.D., S.J. Goldberg, M.Z. Mays, and B.V. Dawson. 2003. Threshold of trichloroeth-

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

ylene contamination in maternal drinking waters affecting fetal heart development in the rat. Environ. Health Perspect. 111(3):289-292.

Johnsrud, E.K., S.B. Koukouritaki, K. Divakaran, L.L. Brunengraber, R.N. Hines, and D.G. McCarver. 2003. Human hepatic CYP2E1 expression during development. J. Pharmacol. Exp. Ther. 307(1):402-407.

Kalant, H., J.M. Khanna, and J. Loth. 1970. Effect of chronic intake of ethanol on pyridine nucleotide levels in rat liver and kidney. Can. J. Physiol. Pharmacol. 48(8):542-549.

Kalkuhl, A., J. Troppmair, A. Buchmann, S. Stinchcombe, C.L. Buenemann, U.R. Rapp, K. Kaestner, and M. Schwartz. 1998. p21 Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between RAS-mutated and RASwild-type lesions. Hepatology 27(4):1081-1088.

Kaneko, T., P.Y. Wang, and A. Sato. 1997. Assessment of the health effects of trichloroethylene. Ind. Health 35(3):301-324.

Kaneko, T., M. Saegusa, K. Tasaka, and A. Sato. 2000. Immunotoxicity of trichloroethylene: A study with MRL-lpr/lpr mice. J. Appl. Toxicol. 20(6):471-475.

Kato-Weinstein, J., M.K. Lingohr, G.A. Orner, B.D. Thrall, and R.J. Bull. 1998. Effects of dichloroacetate on glycogen metabolism in B6C3F1 mice. Toxicology 130(2-3):141-154.

Kato-Weinstein, J., A.J. Stauber, G.A. Orner, B.D. Thrall, and R.J. Bull. 2001. Differential effects of dihalogenated and trihalogenated acetates in the liver of B6C3F1 mice. J. Appl. Toxicol. 21(2):81-89.

Kauffman, S.L. 1981. Histogenesis of the papillary Clara cell adenoma. Am. J. Pathol. 103(2):174-180.

Kauffman, S.L., L. Alexander, and L. Sass. 1979. Histologic and ultrastructural features of the Clara cell adenoma of the mouse lung. Lab. Invest. 40(6):708-716.

Kauffmann, B.M., K.L. White, Jr., V.M. Sanders, K.A. Douglas, L.E. Sain, J.F. Borzelleca, and A.E. Munson. 1982. Humoral and cell-mediated immune status in mice exposed to chloral hydrate. Environ. Health Perspect. 44:147-151.

Keeter, S., R.M. Benator, S.M. Weinberg, and M.A. Hartenberg. 1990. Sedation in pediatric CT: National survey of current practice. Radiology 175(3):745-752.

Kelley, J.M., and B.R. Brown, Jr. 1974. Biotransformation of trichloroethylene. Intern. Anesthesiol. Clin.12(2):85-92.

Kelsh, M.A., M. Weingart, J. Mandel, P. Mink, D. Alexander, R. Basu, R. Kalmes, and M. Goodman. 2005. A Meta-Analysis of Epidemiology Studies of Occupational TCE Exposure and Selected Cancers. Presentation by M.A. Kelsh at the Third Meeting on Assessing Human Health Risks of Trichloroethylene, June 9, 2005, Irvine, CA.

Kennedy, G.L., J.L. Butenhoff, G.W. Olsen, J.C. O’Connor, A.M. Seacat, R.C. Perkins, L.B. Biegel, S.R. Murphy, and D.G. Farrar. 2004. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 34(4):351-384.

Ketcha, M.M., D.K. Stevens, D.A. Warren, C.T. Bishop, and W.T. Brashear. 1996. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J. Anal. Toxicol. 20(4):236-241.

Keys, D.A., J.V. Bruckner, S. Muralidhara, and J.W. Fisher. 2003. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene. Toxicol. Sci. 76(1):35-50.

Keys, D.A., I.R. Schultz, D.A. Mahle, and J.W. Fisher. 2004. A quantitative description of suicide inhibition of dicloroacetic acid in rats and mice. Toxicol. Sci. 82(2):381-393.

Khan, M.F., B.S. Kaphalia, B.S. Prabhakar, M.F. Kanz, and G.A. Ansari. 1995. Trichloroethene-induced autoimmune response in femal MRL +/- mice. Toxicol. Appl. Pharmacol. 134(1):155-160.

Khan, M.F., X. Wu, and G.A. Ansari. 2001. Antimalondialdehyde antibodies in MRL +/+ mice

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

treated with trichloroethene and dichlroacetyl chloride: Possible role of lipid peroxidation in autoimmunity. Toxicol. Appl. Pharmacol. 170(2):88-92.

Khattak, S., G.K. Moghtader, K. McMartin, M. Barrera, D. Kennedy, and G. Koren. 1999. Pregnancy outcome following gestational exposure to organic solvents. JAMA 281(12): 1106-1109.

Kilburn, K.H. 2002a. Is neurotoxicity associated with environmental trichloroethylene (TCE)? Arch. Environ. Health 57(2):113-120.

Kilburn, K.H. 2002b. Do duration of exposure, proximity to electronic manufacturing plants, and involvement in a lawsuit affect chlorinated solvent toxicity? Arch. Environ. Health 57(2):121-126.

Kishi, R., I. Harabuchi, T. Ikeda, Y. Katakura, and H. Miyake. 1993. Acute effects of trichloroethylene on blood concentrations and performance decrements in rats and their relevance to humans. Br. J. Ind. Med. 50(5):470-480.

Klaunig, J.E., R.J. Ruch, and E.L. Lin. 1989. Effects of trichloroethylene and its metabolites on rodent hepatocyte intercellular communication. Toxicol. Appl. Pharmacol. 99(3):454-465.

Klaunig, J.E., J.C. Siglin, L.D. Schafer, J.A. Hartnett, C.M. Weghorst, and M.J. Olson. 1991. Correlation between species and tissue sensitivity to chemical carcinogenesis in rodents and the induction of DNA synthesis. Pp. 185-194 in Chemically Induced Cell Proliferation: Implications for Risk Assessment, B.E. Butterworth, T.J. Slaga, W. Farland, and M. McClain, eds. Progress in Clinical and Biological Research, Vol. 369. New York: Wiley-Liss.

Klaunig, J.E., M.A. Babich, K.P. Baetcke, J.C. Cook, J.C. Corton, R.M. David, J.G. DeLuca, D.Y. Lai, R.H. McKee, J.M. Peters, R.A. Roberts, and P.A. Fenner-Crisp. 2003. PPARalpha agonist-induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33(6):655-780.

Koch, O.R., G. Pani, S. Borrello, R. Colavitti, A. Cravero, S. Farre, and T. Galeotti. 2004. Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol. Aspects Med. 25(1-2):191-198.

Kochen, W., D. Kohlmuller, P. De Biasi, and R. Ramsay. 2003. The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson’s disease. Adv. Exp. Med. Biol. 527:253-263.

Koechel, D.A., M.E. Krejci, and R.E. Ridgewell. 1991. The acute effects of S-(1,2-dichlorovinyl)-L-cysteine and related chemicals on renal function and ultrastructure in the pentobarbital-anesthetized dog: Structure-activity relationships, biotransformation, and unique site-specific nephrotoxicity. Fundam. Appl. Toxicol. 17(1):17-33.

Koivula, T. 1975. Subcellular distribution and characterization of human liver aldehyde dehydrogenase fractions. Life Sci. 16(10):1563-1569.

Kokko, H. 2005. Useful ways of being wrong. J. Evol. Biol. 18(5):1155-1157.

Korrapati, M.C., E.A. Lock, and H.M. Mehendale. 2005. Molecular mechanisms of enhanced cell division in protection against 1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death. Am. J. Physiol. Renal Physiol. 289(1):F175-F185.

Kraupp-Grasl, B., W. Huber, B. Putz, U. Gerbracht, and R. Schulte-Hermann. 1990. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res. 50(12):3701-3708.

Krause, R.J., L.H. Lash, and A.A. Elfarra. 2003. Human kidney flavin-containing monooxygenases and their potential roles in cysteine s-conjugate metabolism and nephrotoxicity. J. Pharmacol. Exp. Ther. 304(1):185-191.

Krupenko, S.A., C. Wagner, and R.J. Cook. 1997. Domain structure of rat 10-formyltetrahydrofolate dehydrogenase. Resolution of the amino-terminal domain as 10-formyltetrahydrofolate hydrolase. J. Biol. Chem. 272(15):10273-10278.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Kuehl, P., J. Zhang, Y. Lin, J. Lamba, M. Assem, J. Schuetz, P.B. Watkins, A. Daly, S.A. Wrighton, S.D. Hall, P. Maurel, M. Relling, C. Brimer, K. Yasuda, R. Venkataramanan, S. Strom, K. Thummel, M.S. Boguski, and E. Schuetz. 2001. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 27(4):383-391.

Kukongviriyapan, V., U. Kukongviriyapan, and N.H. Stacey. 1990. Interference with hepatocellular substrate uptake by 1,1,1-trichloroethane and tetrachloroethylene. Toxicol. Appl. Pharmacol. 102(1):80-90.

Kumar, P., A.K. Prasad, D.K. Saxena, U. Mani, B.K. Maji, and K.K. Dutta. 2000a. Fertility and general reproduction studies in trichloroethylene exposed rats. Indian J. Occup. Health 43(3):117-126.

Kumar, P., A.K. Prasad, and K.K. Dutta. 2000b. Steroidogenic alterations in testes and sera of rats exposed to trichloroethylene (TCE) by inhalation. Hum. Exp. Toxicol. 19(2):117-121.

Kumar, P., A.K. Prasad, B.K. Maji, U. Mani, and K.K. Dutta. 2001a. Hepatoxic alterations induced by inhalation of trichlorethylene (TCE) in rats. Biomed. Environ. Sci. 14(4): 325-332.

Kumar, P., A.K. Prasad, U. Mani, B.K. Maji, and K.K. Dutta. 2001b. Trichloroethylene induced testicular toxicity in rats exposed by inhalation. Hum. Exp. Toxicol. 20(11):585-589.

Kyrklund, T., G. Goracci, K.G. Haglid, L. Rosengren, G. Porcellait, and P. Kjellstrand. 1984. Chronic effects of trichlororethylene upon S-100 protein content and lipid composition in gerbil cerebellum. Scand. J. Work Environ. Health. 10(2):89-93.

Labrune, P., P. Trioche, I. Duvaltier, P. Chevalier, and M. Odievre. 1997. Hepatocellular adenomas in glycogen storage disease type I and III: A series of 43 patients and review of the literature. J. Pediatr. Gastroenterol. Nutr. 24(3):276-279.

Lagakos, S.W., B.J. Wessen, and M. Zelen. 1986. An analysis of contaminated well water and heatlh effects in Woburn, Massachusetts. J. Am. Stat. Assoc. 81(395):583-596.

Lai, D.Y. 2004. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 22(1):37-55.

Lambert, G.H., D.A. Schoeller, A.N. Kotake, C. Flores, and D. Hay. 1986. The effect of age, gender, and sexual maturation on the caffeine breath test. Dev. Pharmacol. Ther. 9(6):375-388.

Lambert, G.H., J. Muraskas, C.L. Anderson, and T.F. Myers. 1990. Direct hyperbilirubinemia associated with chloral hydrate administration in the newborn. Pediatrics 86(2):277-281.

Land, P.C., E.L. Owen, and H.W. Linde. 1981. Morphologic changes in mouse spermatozoa after exposure to inhalational anesthetics during early spermatogenesis. Anesthesiology 54(1):53-56.

Lane, J.T. 2004. Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: A temporal perspective. Am. J. Physiol. Renal. Physiol. 286(3):F442-F450.

Larson, J.L., and R.J. Bull. 1989. Effect of ethanol on the metabolism of trichloroethylene. J. Toxicol. Environ. Health 28(4):395-406.

Larson, J.L., and R.J. Bull. 1992a. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol. Appl. Pharmacol. 115(2):278-285.

Larson, J.L., and R.J. Bull. 1992b. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol. Appl. Pharmacol. 115(2):268-277.

Lash, L.H. 2004. Metabolism and Mechanisms of Renal Cellular Injury Induced by Trichloroethylene. Presentation at EPA Symposium on New Scientific Research Related to the Health Effects of TCE, February 26-27, 2004, Washington, DC.

Lash, L.H., and M.W. Anders. 1986. Cytotoxicity of S-(1,2-dichlorovinyl)glutathione and

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

S-(1,2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. J. Biol. Chem. 261(28): 13076-13081.

Lash, L.H., and J.C. Parker. 2001. Hepatic and renal toxicities associated with perchloroethylene. Pharmacol. Rev. 53(2):177-208.

Lash, L.H., D.P. Jones, and M.W. Anders. 1988. Glutathione homeostasis and glutathione S- conjugate toxicity in kidney. Rev. Biochem. Toxicol. 9:29-67.

Lash, L.H., P.J. Sausen, R.J. Duescher, A.J. Cooley, and A.A. Elfarra. 1994. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: Studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. J. Pharmacol. Exp. Ther. 269(1):374-383.

Lash, L.H., Y. Xu, A.A. Elfarra, R.J. Duescher, and J.C. Parker. 1995. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab. Dispos. 23(8):846-853.

Lash, L.H., W. Qian, D.A. Putt, K. Jacobs, A.A. Elfarra, R.J. Krause, and J.C. Parker. 1998. Glutathione conjugation of trichloroethylene in rats and mice: Sex-, species-, and tissuedependent differences. Drug Metab. Dispos. 26(1):12-19.

Lash, L.H., D.A. Putt, W.T. Brashear, R. Abbas, J.C. Parker, and J.W. Fisher. 1999. Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene. J. Toxicol. Environ. Health A 56(1):1-21.

Lash, L.H., J.W. Fisher, J.C. Lipscomb, and J.C. Parker. 2000a. Metabolism of trichloroethylene. Environ. Health Perspect. 108(Suppl. 2):177-200.

Lash, L.H., J.C. Parker, and C.S. Scott. 2000b. Modes of action of trichloroethylene for kidney tumorigenesis. Environ. Health Perspect. 108(Suppl. 2):225-240.

Lash, L.H., S.E. Hueni, and D.A. Putt. 2001a. Apoptosis, necrosis, and cell proliferation induced by S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells. Toxicol. Appl. Pharmacol. 177(1):1-16.

Lash, L.H., W. Qian, D.A. Putt, S.E. Hueni, A.A. Elfarra, R.J. Krause, and J.C. Parker. 2001b. Renal and hepatic toxicity of trichloroethylene and its glutathione-derived metabolites in rats and mice: Sex-, species-, and tissue-dependent differences. J. Pharmacol. Exp. Ther. 297(1):155-164.

Lash, L.H., W. Qian, D.A. Putt, S.E. Hueni, A.A. Elfarra, A.R. Sicuri, and J.C. Parker. 2002. Renal toxicity of perchloroethylene and S-(1,2,2-trichlorovinyl)glutathione in rats and mice: Sex- and species-dependent differences. Toxicol. Appl. Pharmacol. 179(3): 163-171.

Lash, L.H., D.A. Putt, S.E. Hueni, R.J. Krause, and A.A. Elfarra. 2003. Roles of necrosis, apoptosis, and mitochondrial dysfunction in S-(1,2-dichlorovinyl)-L-cysteine sulfoxide-induced cytotoxicity in primary cultures of human renal proximal tubular cells. J. Pharmacol. Exp. Ther. 305(3):1163-1172.

Lash, L.H., D.A. Putt, and J.C. Parker. 2006. Metabolism and tissue distribution of orally administered trichloroethylene in male and female rats: Identification of glutathioneand cytochrome p-450-derived metabolites in liver, kidney, blood, and urine. J. Toxicol. Environ. Health A 69(13):1285-1309.

Lash, T.L., and A.K. Fink. 2003. Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology 14(4):451-458.

Latendresse, J.R., and M.A. Pereira. 1997. Dissimilar characteristics of N-methyl-N-nitrosourea-initiated foci and tumors promoted by dichloroacetic acid or trichloroacetic acid in the liver of female B6C3F1 mice. Toxicol. Pathol. 25(5):433-440.

Laughter, A.R., C.S. Dunn, C.L. Swanson, P. Howroyd, R.C. Cattley, and J.C. Corton. 2004. Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver. Toxicology 203(1-3):83-98.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Leakey, J.E., J.E. Seng, J.R. Latendresse, N. Hussain, L.J. Allen, and W.T. Allaben. 2003a. Dietary controlled carcinogenicity study of chloral hydrate in male B6C3F1 mice. Toxicol. Appl. Pharmacol. 193(2):266-280.

Leakey, J.E., J.E. Seng, and W.T. Allaben. 2003b. Body weight considerations in the B6C3F1 mouse and the use of dietary control to standardize background tumor incidence in chronic bioassay. Toxicol. Appl. Pharmacol. 193(2):237-265.

Lee, K., J.V. Bruckner, S. Muralidhara, and J.M. Gallo. 1996. Characterization of presystemic elimination of trichloroethylene and its nonlinear kinetics in rats. Toxicol. Appl. Pharmacol. 139(2):362-271.

Lee, K.M., S. Muralidhara, R.G. Schnellmann, and J.V. Bruckner. 2000. Contribution of direct solvent injury to the dose-dependent kinetics of trichloroethylene: Portal vein administration to rats. Toxicol. Appl. Pharmacol. 164(1):46-54.

Lee, L.J., C.W. Chung, Y.C. Ma, G.S. Wang, P.C. Chen, Y.H. Hwang, and J.D. Wang. 2003. Increased mortality odds ratio of male liver cancer in a community contaminated by chlorinated hydrocarbons in groundwater. Occup. Environ. Med. 60(5):364-369.

Lehmann, I., A. Thoelke, M. Rehwagen, U. Rolle-Kampczyk, U. Schlink, R. Schulz, M. Borte, U. Diez, and O. Herbarth. 2002. The influence of maternal exposure to volatile organic compounds on the cytokine secretion profile of neonatal T cells. Environ. Toxicol. 17(3):203-210.

Leibman, K.C., and W.J. Mc Allister, Jr. 1967. Metabolism of trichloroethylene in liver microsomes. III. Induction of its enzymatic activity and its effect on excretion of metabolites. J. Pharmacol. Exp. Ther. 157(3):574-580.

Le Moual, N., R. Bakke, E. Orlowski, D. Heederik, H. Kromhout, S.M. Kennedy, B. Rijcken, and F. Kauffmann. 2000. Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exposure matrices (ECOJEM). Occup. Environ. Med. 57(2):126-132.

Lerman, J., H.A. Strong, K.M. LeDez, J. Swartz, M.J. Rieder, and F.A. Burrows. 1989. Effects of age on the serum concentration of alpha 1-acid glycoprotein and the binding of lidocaine in pediatric patients. Clin. Pharmacol. Ther. 46(2):219-225.

Leroux, B.G., W.M. Leisenring, S.H. Moolgavkar, and E.M. Faustman. 1996. A biologicallybased dose-response model for developmental toxicology. Risk Anal. 16(4):449-458.

Leuschner, J., and L. Leuschner. 1991. Evaluation of the mutagenicity of chloral hydrate in vitro and in vivo. Arzneimittelforschung. 41(10):1101-1103.

Lewis, G.D., R.C. Reynolds, and A.R. Johnson. 1984. Some effects of trichloroethylene on mouse lungs and livers. Gen. Pharmacol. 15(2):139-144.

Li, C.Y., and F.C Sung. 1999. A review of the healthy worker effect in occupational epidemiology. Occup. Med. 49(4):225-229.

Liangpunsakul, S., D. Kolwankar, A. Pinto, J.C. Gorski, S.D. Hall, and N. Chalasani. 2005. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: A comparison with nonalcoholics. Hepatology 41(5):1144-1150.

Lieber, C.S. 2004. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab. Rev. 36(3-4):511-529.

Light, R.J., and D.B. Pillemer. 1984. Summing Up: The Science of Reviewing Research. Cambridge, MA: Harvard University Press.

Ligocki, M.P., C. Leuenberger, and J.F. Pankow. 1985. Trace organic compounds in rain II. Gas scavenging of neutral organic compounds. Atmos. Environ. 19(10):1619-1626.

Lindbohm, M.L., H. Taskinen, M. Sallmen, and K. Hemminki. 1990. Spontaneous abortions among women exposed to organic solvents. Am. J. Ind. Med. 17(4):449-463.

Lingohr, M.K., B.D. Thrall, and R.J. Bull. 2001. Effects of dichloroacetate (DCA) on serum

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

insulin levels and insulin-controlled signaling proteins in livers of male B6C3F1 mice. Toxicol. Sci. 59(1):178-184.

Lingohr, M.K., R.J. Bull, J. Kato-Weinstein, and B.D. Thrall. 2002. Dichloroacetate stimulates glycogen accumulation in primary hepatocytes through an insulin-independent mechanism. Toxicol. Sci. 68(2):508-515.

Lipscomb, J.A., L. Fenster, M. Wrensch, D. Shusterman, and S. Swan. 1991. Pregnancy outcomes in women potentially exposed to occupational solvents and women working in the electronics industry. J. Occup. Med. 33(5):597-604.

Lipscomb, J.C., D.A. Mahle, W.T. Brashear, and H.A. Barton. 1995. Dichloroacetic acid: Metabolism in cytosol. Drug. Metab. Dispos. 23(11):1202-1205.

Lipscomb, J.C., D.A. Mahle, W.T. Brashear, and C.M. Garrett. 1996. A species comparison of chloral hydrate metabolism in blood and liver. Biochem. Biophys. Res. Commun. 227(2):340-350.

Lipscomb, J.C., C.M. Garrett, and J.E. Snawder. 1997. Cytochrome P450-dependent metabolism of trichloroethylene: Interindividual differences in humans. Toxicol. Appl. Pharmacol. 142(2):311-318.

Lipscomb, J.C., J.W. Fisher, P.D. Confer, and J.Z. Byczkowski. 1998. In vitro to in vivo extrapolation for trichloroethylene metabolism. Toxicol. Appl. Pharmacol. 152(2):376-367.

Lipscomb, J.C., L.K. Teuschler, J. Swartout, D. Popken, T. Cox, and G.L. Kedderis. 2003. The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans. Risk Anal. 23(6):1221-1238.

Lloyd, J.W. 1971. Long-term mortality study of steelworkers. V. Respiratory cancer in coke plant workers. J. Occup. Med. 13(2):53-68.

Lloyd, J.W., and A. Ciocco. 1969. Long-term mortality study of steelworkers. I. Methodology. J. Occup. Med. 11(6):299-310.

Lockey, J.E., C.R. Kelly, G.W. Cannon, T.V. Colby, V. Aldrich, and G.K. Livingston. 1987. Progressive systemic sclerosis associated with exposure to trichloroethylene. J. Occup. Med. 29(6):493-496.

Loeber, C.P., and R.B. Runyan. 1990. A comparison of fibronectin, laminin, and galactosyltransferase adhesion mechanisms during cardiac mesenchymal cell migration in vitro. Dev. Biol. 140(2):401-412.

Loeber, C.P., M.J. Hendrix, S. Diez de Pinos, and S.J. Goldberg. 1988. Trichloroethylene: A cardiac teratogen in developing chick embryos. Pediatr. Res. 24(6):740-744.

Loffredo, C, C. Ferencz, and A. Correa-Villasenor. 1991. Organic solvents and cardiovascular malformations in the Baltimore-Washington infant study. Teratology 43(5):450.

Longnecker, M.P., M.A. Klebanoff, D.B. Dunson, X. Guo, Z. Chen, H. Zhou, and J.W. Brock. 2005. Maternal serum level of the DDT metabolite DDE in relation to fetal loss in previous pregnancies. Environ. Res. 97(2):127-133.

Lopreato, G.F., R. Phelan, C.M. Borghese, M.J. Beckstead, and S.J. Mihic. 2003. Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend. 70(1):11-15.

Lorente, C., S. Cordier, A. Bergeret, H.E. De Walle, J. Goujard, S. Ayme, R. Knill-Jones, E. Calzolari, and F. Bianchi. 2000. Maternal occupational risk factors for oral clefts. Occupational Exposure and Congenital Malformation Working Group. Scand. J. Work Environ. Health 26(2):137-145.

Lowengart, R.A., J.M. Peters, C. Cicioni, J. Buckley, L. Bernstein, S. Preston-Martin, and E. Rappaport. 1987. Childhood leukemia and parents’ occupational and home exposures. J. Natl. Cancer Inst. 79(1):39-46.

Lumpkin, M.H., J.V. Bruckner, J.L. Campbell, C.E. Dallas, C.A. White, and J.W. Fisher. 2003. Plasma binding of trichloroacetic acid in mice, rats, and humans under cancer bioassay and environmental exposure conditions. Drug Metab. Dispos. 31(10):1203-1207.

Luster, M.I., A.E. Munson, P.T. Thomas, M.P. Holsapple, J.D. Fenters, K.L. White, Jr.,

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

L.D. Lauer, D.R. Germolec, G.J. Rosenthal, and J.H. Dean. 1988. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program’s guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10(1):2-19.

Luster, M.I., C. Portier, D.G. Pait, K.L. White, Jr, C. Gennings, A.E. Munson, and G.J. Rosenthal. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18(2):200-210.

Lutz, W.K. 1990. Dose-response relationship and low dose extrapolation in chemical carcinogenesis. Carcinogenesis 11(8):1243-1247.

Main, K.M., M. Jarden, L. Angelo, B. Dinesen, N.T. Hertel, A. Juul, J. Muller, and N.E. Skakkebaek. 1994. The impact of gender and puberty on reference values for urinary growth hormone excretion: A study of 3 morning urine samples in 517 healthy children and adults. J. Clin. Endocrinol. Metab. 79(3):865-871.

Maloney, E.K., and D.J. Waxman. 1999. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 161(2): 209-218.

Maltoni, C, G. Lefemine, and G. Cotti. 1986. Experimental Research on Trichloroethylene Carcinogenesis, Archives of Research on Industrial Carcinogenesis, Vol. V, C. Maltoni, and MA Mehlman, eds. Princeton, NJ: Princeton Scientific Publishing Co.

Maltoni, C., G. Lefemine, G. Cotti, and G. Perino. 1988. Long-term carcinogenicity bioassays on trichloroethylene administered by inhalation to Sprague-Dawley rats and Swiss and B6C3F1 mice. Ann. NY Acad. Sci. 534:316-342.

Mandel, J., and M. Kelsh. 2001. A review of the epidemiology of trichloroethylene and kidney cancer. Hum. Ecol. Risk Assess. 7(4):727-735.

Mandel, J.S., J.K. McLaughlin, B. Schlehofer, A. Mellemgaard, U. Helmert, P. Lindblad, M. McCredie, and H.O. Adami. 1995. International renal-cell cancer study. IV. Occupation. Int. J. Cancer 61(5):601-605.

Mannervik, B. 1985. The isoenzymes of glutathione transferase. Adv. Enzymol. Relat. Areas Mol. Biol. 57:357-417.

Mannervik, B., Y.C. Awasthi, P.G. Board, J.D. Hayes, C. Di Ilio, B. Ketterer, I. Listowsky, R. Morgenstern, M. Muramatsu, W.R. Pearson, C.B. Pickett, K. Sato, M. Widersten, and C.R. Wolf. 1992. Nomenclature for human glutathione transferases. Biochem. J. 282(Pt 1):305-306.

Manson, J.M., M. Murphy, N. Richdale, and M.K. Smith. 1984. Effects of oral exposure to trichloroethylene on female reproductive function. Toxicology 32(3):229-242.

Markwald, R.R., R.B. Runyan, G.T. Kitten, F.M. Funderburg, D.H. Bernanke, and P.R. Brayer. 1984. Use of collagen gel cultures to study heart development: Preteoglycan and glycoprotein interactions during formation of endocardial cushion tissue. Pp. 323-350 in The Role of Extracellular Matrix in Development, R.L. Trelstad, ed. New York, NY: Alan R. Liss.

Markwald, R.R., C. Eisenberg, L. Eisenberg, T. Trusk, and Y. Sugi. 1996. Epithelial-mesenchymal transformations in early avian heart development. Acta Anat. 156(3):173-186.

Marsh, G.M., A.O. Youk, R.A. Stone, J.M. Buchanich, M.J. Gula, T.J. Smith, and M.M. Quinn. 2001. Historical cohort study of US man-made vitreous fiber production workers: I. 1992 fiberglass cohort follow-up: Initial findings. J. Occup. Environ. Med. 43(9): 741-756.

Marshall, E.K., and A.H. Owens, Jr. 1954. Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol. Bull. Johns Hopkins Hosp. 95(1):1-18.

Marsman, D.S., R.C. Cattley, J.G. Conway, and J.A. Popp. 1988. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis in the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48(3):6730-6744.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Mather, G.G., J.H. Exon, and L.D. Koller. 1990. Subchronic 90 day toxicity of dichloroacetic and trichloroacetic acid in rats. Toxicology 64(1):71-80.

Mattsson, J.L., R.R. Albee, L.G. Lomax, M.J. Beckman, and P.J. Spencer. 1993. Neurotoxicological examination of rats exposed to 1,1,1-trichloroethylene vapor for 13 weeks. Neurotoxicol. Teratol. 15(5):313-326.

Maxwell, G.M. 1984. Principals of Paediatric Pharmacology. New York: Oxford University Press.

Mayers, D.J., K.W. Hindmarsh, K. Sankaran, D.K. Gorecki, and G.F. Kasian. 1991. Chloral hydrate disposition following single-dose administration to critically ill neonates and children. Dev. Pharmacol. Ther. 16(2):71-77.

Mayers, D.J., K.W. Hindmarsh, D.K. Gorecki, and K. Sankaran. 1992. Sedative/hypnotic effects of chloral hydrate in the neonate: Trichloroethanol or parent drug? Dev. Pharmacol. Ther. 19(2-3):141-146.

McCarley, K.D., and A.L. Bunge. 2001. Pharmacokinetic models of dermal absorption. J. Pharm. Sci. 90(11):1699-1719.

McCarver, D.G. 2004. Applicability of the principles of developmental pharmacology to the study of environmental toxicants. Pediatrics 113(suppl. 4):969-972.

McCarver, D.G., and R.N. Hines. 2002. The ontogeny of human drug-metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms. J. Pharmacol. Exp. Ther. 300(2):361-366.

McCarver, D.G., H.R. Thomasson, S.S. Martier, R.J. Sokol, and T. Li. 1997. Alcohol dehydrogenase-2*3 allele protects against alcohol-related birth defects among African Americans. J. Pharmacol. Exp. Ther. 283(3):1095-1101.

McCarver, D.G., R. Byun, R.N. Hines, M. Hichme, and W. Wegenek. 1998. A genetic polymorphism in the regulatory sequences of human CYP2E1: Association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol. Appl. Pharmacol. 152(2):276-281.

McCredie, M., and J.H. Stewart. 1993. Risk factors for kidney cancer in New South Wales. IV. Occupation. Br. J. Ind. Med. 50(4):349-354.

McCullagh, P., and J.A. Nelder. 1989. Generalized Linear Models, 2nd Ed. London: Chapman and Hall.

McDaniel, T.V., P.A. Martin, N. Ross, S. Brown, S. Lesage, and B.D. Pauli. 2004. Effects of chlorinated solvents on four species of North American amphibians. Arch. Environ. Contam. Toxicol. 47(1):101-109.

McDonald, J.C., J. Lavoie, R. Cote, and A.D. McDonald. 1987. Chemical exposures at work in early pregnancy and congenital defect: A case-referent study. Br. J. Ind. Med. 44(8):527-533.

McGuire, V., L.M. Nelson, T.D. Koepsell, H. Checkoway, and W.T. Longstreth, Jr. 1998. Assessment of occupational exposures in community-based case-control studies. Annu. Rev. Public Health 19:35-53.

McKinney, P.A., N.T. Fear, and D. Stockton. 2003. Parental occupation at periconception: Findings from the United Kingdom childhood cancer study. Occup. Environ. Med. 60(12):901-909.

McLaughlin, J.K., and W.J. Blot. 1997. A critical review of epidemiology studies of trichloroethylene and perchloroethylene and risk of renal-cell cancer. Int. Arch. Occup. Environ. Health 70(4):222-231.

McLaughlin, J.K., W.J. Blot, S.S. Devesa, and J.F. Fraumeni, Jr. 1996. Renal cancer. Pp. 11421155 in Cancer Epidemiology and Prevention, 2nd Ed. D. Schottenfeld, and J.F. Fraumeni, eds. New York: Oxford University Press.

McMartin, K.I., M. Chu, E. Kopecky, T.R. Einarson, and G. Koren. 1998. Pregnancy outcome

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

following maternal organic solvent exposure: A meta-analysis of epidemiologic studies. Am. J. Ind. Med. 34(3):288-292.

MDPH/CDC/MHRI (Massachusetts Department of Public Health/ U.S. Centers for Disease Control and Prevention/ Massachusetts Health Research Institute). 1994. Woburn Environment and Birth Study. Massachusetts Department of Public Health, Bureau of Environmental Health Assessment; U.S. Centers for Disease Control and Prevention, Division of Birth Defects and developmental Disabilities; and Massachusetts Health Research Institute. August 1994.

Mellemgaard, A., G. Engholm, J.K. McLaughlin, and J.H. Olsen. 1994. Occupational risk factors for renal-cell carcinoma in Denmark. Scand. J. Work Environ. Health 20(3): 160-165.

Melnick, R.L. 2001. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)? Environ. Health Perspect. 109(5):437-442.

Mensing, T., P. Welge, B. Voss, L.M. Fels, H.H. Fricke, T. Bruning, and M. Wilhelm. 2002. Renal toxicity after chronic inhalation exposure of rats to trichloroethylene. Toxicol. Lett. 128(1-3):243-247.

Merdink, J.L., A. Gonzalez-Leon, R.J. Bull, and I.R. Schultz. 1998. The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice. Toxicol. Sci. 45(1):33-41.

Miller, J.H., K. Minard, R.A. Wind, G.A. Orner, L.B. Sasser, and R.J. Bull. 2000. In vivo MRI measurements of tumor growth induced by dichloroacetate: Implications for mode of action. Toxicology 145(2-3):115-125.

Miller, R.E., and F.P. Guengerich. 1982. Oxidation of trichloroethvlene by liver microsomal cytochrome P-450: Evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry 21(5):1090-1097.

Miller, R.E., and F.P. Guengerich. 1983. Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted systems containing cytochrome P-450. Cancer Res. 43(3):1145-1152.

Mjaatvedt, C.H., R.C. Lepera, and R.R. Markwald. 1987. Myocardial specificity for initiating endothelial-mesenchymal cell transition in embryonic chick heart correlates with particulate distribution of fibronectin. Dev. Biol. 119(1):59-67.

Mjaatvedt, C.H., E.L. Krug, and R.R. Markwald. 1991. An antiserum (ES1) against a particulate form of extracellular matrix blocks the transition of cardiac endothelium into mesenchyme in culture. Dev. Biol. 145(2):219-230.

Monson, R.R. 1974. Letter: Value of proportionate mortality ratio in epidemiologic studies. N. Engl. J. Med. 291(14):740.

Moody, D.E., and J.K. Reddy. 1978. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome- associated enzymes. Am. J. Pathol. 90(2):435-450.

Moore, M.M., and K. Harrington-Brock. 2000. Mutagenicity of trichloroethylene and its metabolites: Implications for the risk assessment of trichloroethylene. Environ. Health Perspect. 108(Suppl. 2):215-223.

Morgan, J.W., and R.E. Cassady. 2002. Community cancer assessment in response to longtime exposure to perchlorate and trichloroethylene in drinking water. J. Occup. Environ. Med. 44(7):616-621.

Morgan, M.G., M. Henrion, and M. Small. 1990. Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis. Cambridge, UK: Cambridge University Press.

Morgan, R.W., M.A. Kelsh, K. Zhao, and S. Heringer. 1998. Mortality of aerospace workers exposed to trichloroethylene. Epidemiology 9(4):424-431.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Morgenstern, H. 1998. Ecologic studies. Pp. 459-480 in Modern Epidemiology, 2nd Ed., K.J. Rothman, and S. Greenland, eds. New York, NY: Lippincott -Raven.

Mosegaard, K., and A. Tarantola. 1995. Monte Carlo sampling of solutions to inverse problems. J. Geophys. Res. 100(B7):12431-12447.

Moser, V.C., P.M. Phillips, K.L. McDaniel, and R.C. MacPhail. 1999. Behavioral evaluation of the neurotoxicity produced by dichloroacetic acid in rats. Neurotoxicol. Teratol. 21(6):719-731.

Moslen, M.T., E.S. Reynolds, and S. Szabo. 1977. Enhancement of metabolism and hepatotoxicity of trichloroethylene and perchloroethylene. Biochem. Pharmacol. 26(5):369-375.

Mounho, B.J., and B.D. Thrall. 1999. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitro. Toxicol. Appl. Pharmacol. 159(2):125-133.

Muller, G., M. Spassowski, and D. Henschler. 1972. Trichloroethylene exposure and trichloromethylene metabolites in urine and blood. Arch. Toxicol. 29(4).335-340.

Muller, G., M. Spassovski, and D. Henscler. 1974. Metabolism of trichloroethylene in man. II. Pharmacokinetics of metabolites. Arch. Toxicol. 32(4):283-295.

Muller, G., M. Spassowski, and D. Henschler. 1975. Metabolism of trichloroethylene in man. III: Interaction of trichloroethylene and ethanol. Arch. Toxicol. 33(3):173-189.

Muller, M., G. Birner, and W. Dekant. 1998. Reactivity of haloketenes and halothioketenes with nucleobases: Chemical characterization of reaction products. Chem. Res. Toxicol. 11(5):454-463.

Nagaya, T., N. Ishikawa, H. Hata, and T. Otobe. 1993. Subclinical and reversible hepatic effects of occupational exposure to trichloroethylene. Int. Arch. Occup. Environ. Health 64(8):561-563.

Nakajima, T., Y. Koyama, and A. Sato. 1982. Dietary modification of metabolism and toxicity of chemical substances—with special reference to carbohydrate. Biochem. Pharmacol. 31(6):1005-1011.

Nakajima, T., T. Okino, S. Okuyama, T. Kaneko, I. Yonekura, and A. Sato. 1988. Ethanol-induced enhancement of trichloroethylene metabolism and hepatotoxicity: Difference from the effect of phenobarbital. Toxicol. Appl. Pharmacol. 94(2):227-237.

Nakajima, T., R.S. Wang, E. Elovaara, S.S. Park, H.V. Gelboin, and H. Vainio. 1992a. A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver. Biochem. Pharmacol. 43(2):251-257.

Nakajima, T., R.S. Wang, Y. Katakura, R. Kishi, E. Elovaara, S.S. Park, H.V. Gelboin, and H. Vainio. 1992b. Sex-, age- and pregnancy-induced changes in metabolism of toluene and trichloroethylene in rat liver in relation to the regulation of cytochrome P450IIE1 and P450IIC11 content. J. Pharmacol. Exp. Ther. 261(3):869-874.

Nakajima, T., R.S. Wang, E. Elovaara, S.S. Park, H.V. Gelboin, and H. Vainio. 1993. Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene and trichloroethylene in liver microsomes. Biochem. Pharmacol. 45(5):1079-1085.

Nakajima, T., Y. Kamijo, N. Usuda, Y. Liang, Y. Fukushima, K. Kametani, F.J. Gonzalez, and T. Aoyama. 2000. Sex-dependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator-activated receptor alpha (PPARalpha). Carcinogenesis 21(4):677-682.

Nakajima, Y., V. Mironov, T. Yamagish, H. Nakamura, and R.R. Markwald. 1997. Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: A role for transforming growth factor -3. Dev. Dyn. 209(3):296-309.

Narotsky, M.G., and R.J. Kavlock. 1995. A multidisciplinary approach to toxicological screening: II. Developmental toxicity. J. Toxicol. Environ. Health 45(2):145-171.

Narotsky, M.G., E.A. Weller, V.M. Chinchilli, and R.J. Kavlock. 1995. Nonadditive devel-

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

opmental toxicity in mixtures of trichloroethylene, di-(20ethylhexyl) phthalate, and heptachlor in 5×3×5 design. Fundam. Appl. Toxicol. 27(2):203-216.

Nau, H., W. Luck, W. Kuhnz, and S. Wegener. 1983. Serum protein binding of diazepam, desmethyldiazepam, furosemide, indomethacin, warfarin, and phenobarbital in human fetus, mother, and newborn infant. Pediatr. Pharmacol. 3(3-4):219-227.

NCI (National Cancer Institute). 1976. Carcinogenesis Bioassay of Trichloroethylene: CAS No. 79-01-6. Carcinogenesis Technical Report No. 2. DHEW (NIH) 76-802. Bethesda, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, Division of Cancer Cause and Prevention, Carcinogensis Program, Carcinogen Bioassay and Program Resources Branch.

Neghab, M., and N.H. Stacey. 1997. Toluene-induced elevation of serum bile acids: Relationship to bile acid transport. J. Toxicol. Environ. Health 52(3): 249-268.

Neghab, M., S. Qu, C.L. Bai, J. Caples, and N.H. Stacey. 1997. Raised concentration of serum bile acids following occupational exposure to halogenated solvents, 1,1,2-trichloro-1,2,2-trifluoroethane and trichloroethylene. Int. Arch. Occup. Environ. Health 70(3):187-194.

Nelson, L.M., W.T. Longstreth, Jr., T.D. Koepsell, H. Checkoway, and G. van Belle. 1994. Completeness and accuracy of interview data from proxy respondents: Demographic, medical, and life-style factors. Epidemiology 5(2):204-217.

Neter, J., M.H. Kutner, C.J. Nachtsheim, and W. Wasserman. 1996. Applied Linear Statistical Models, 4th Ed. Boston, MA: WCB/McGraw-Hill.

Neumark, Y.D., Y. Friedlander, R. Durst, E. Leitersdorf, D. Jaffe, V.A. Ramchandani, S. O’Connor, L.G. Carr, and T.K. Li. 2004. Alcohol dehydrogenase polymorphisms influence alcohol-elimination rates in a male Jewish population. Alcohol Clin. Exp. Res. 28(1):10-14.

Ni, Y.C., T.Y. Wong, R.V. Lloyd, T.M. Heinze, S. Shelton, D. Casciano, F.F. Kadlubar, and P.P. Fu. 1996. Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. Drug Metab. Dispos. 24(1):81-90.

Niederlehner, B.R., J. Cairns, Jr., and E.P. Smith. 1998. Modeling acute and chronic toxicity of nonpolar narcotic chemicals and mixtures to Ceriodaphia dubia. Ecotoxicol. Environ. Saf. 39(2):136-146.

Nietert, P.J., S.E. Sutherland, R.M. Silver, J.P. Pandey, R.G. Knapp, D.G. Hoel, and M. Dosemeci. 1998. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 41(6):1111-1118.

Nietert, P.J., S.E. Sutherland, R.M. Silver, J.P. Pandey, and M. Dosemeci. 1999. Solvent oriented hobbies and the risk of systemic sclerosis. J. Rheumatol. 26(11):2369-2372.

Nieuwenhuijsen, M.J. 2003. Exposure Assessment in Occupational and Environmental Epidemiology. Oxford: Oxford University Press.

Nishiyama, Y., H. Suwa, K. Okamoto, M. Fukumoto, H. Hiai, and S. Toyokuni. 1995. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn. J. Cancer Res. 86(12):1150-1158.

NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press.

NRC (National Research Council). 1988. Health Risks of Radon and Other Internally Deposited Alpha-Emitters. BEIR IV. Washington, DC: National Academy Press.

NRC (National Research Council). 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: National Academy Press.

NTP (National Toxicology Program). 1985. Trichloroethylene (CAS #79-01-6): Reproductive and Rertility Assessment in CD-1 Mice When Administered in the Feed. Report

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

No. RACB84113. Research Triangle Park, NC: National Toxicology Program, National Institute of Environmental Health Sciences.

NTP (National Toxicology Program). 1986a. Trichloroethylene: Reproductive and Fertility Assessment in CD-1 Mice When Administered in the Feed. Report No. NTP-86-068. Research Triangle Park, NC: National Toxicology Program, National Institute of Environmental Health Sciences.

NTP (National Toxicology Program). 1986b. Trichloroethylene: Reproductive and Fertility Assessment in F344 Rats When Administered in the Feed. Report No. NTP-86-085. RTI 153. Research Triangle Park, NC: National Toxicology Program, National Institute of Environmental Health Sciences.

NTP (National Toxicology Program). 1988. NTP Technical Report on the Carcinogenesis Studies of Trichloroethylene (CAS No. 79-01-6) in Four Strains of Rats (ACI, August, Marshall, Osborne-Mendel) (Gavage studies). NTP TR 237. NIH Publication No. 88-2529. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.

NTP (National Toxicology Program). 1990. NTP Technical Report on the Carcinogenesis Studies of Trichloroethylene (Without Epichlorohydrin) (CAS No. 79-01-06) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP TR 243. NIH Publication No. 90-1779. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.

NTP (National Toxicology Program). 2002a. Toxicology and Carcinogenesis Studies of Chloral Hydrate (CAS No. 302-17-0) in B6C3F1 Mice (Gavage Studies). NTP TR 502. NIH Publication No. 02-4436. Research Triangle Park, NC: U.S. Deptment of Health and Human Services, Public Health Service, National Institutes of Health.

NTP (National Toxicology Program). 2002b. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Chloral Hydrate (ad Libitum and Dietary Controlled)(CAS No. 302-17-0) in B6C3F1 mice (Gavage Studies). NTP TR 503. NIH Publication No. 03-4437. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.

Nunes, J., M. Ehrich, and J. Robertson. 2001. Toxicosis associated with dual oral exposure of rats to lead and trichloroethylene. Toxicol. Pathol. 29(4):451-457.

NYDOH (New York State Department of Health). 2005a. Public Health Consultation. Health Statistics Review: Cancer and Birth Outcome Analysis, Endicott Area, Town of Union, Broome County, New York. Public Comment Draft. New York State Department of Health, Center for Environmental Health, Troy, NY. August 23, 2005.

NYDOH (New York State Department of Health). 2005b. Trichloroethene Air Criteria Document. Draft Report. New York State Department of Health, Center for Environmental Health, Troy, NY. August 2005.

O’Brien, M.L., B.T. Spear, and H.P. Glauert. 2005. Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit. Rev. Toxicol. 35(1):61-88.

Odum, J., T. Green, J.R. Foster, and P.M. Hext. 1988. The role of trichloracetic acid and peroxisome proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and rat. Toxicol. Appl. Pharmacol. 92(1):103-112.

Odum, J., J.R. Foster, and T. Green. 1992. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem.Biol. Interact. 83(2):135-153.

O’Flaherty, E.J. 1991. Physiologically based models for bone-seeking elements. II. Kinetics of lead disposition in rats. Toxicol. Appl. Pharmacol. 111(2):313-331

Ohta, M., T. Saito, K. Saito, M. Kurasaki, and T. Hosokawa. 2001. Effect of trichloroethylene on spatiotemporal pattern of LTP in mouse hippocampal slices. Int. J. Neurosci. 111(3-4):257-271.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Ohtsuki, T., K. Sato, A. Koizumi, M. Kumai, and M. Ikeda. 1983. Limited capacity of humans to metabolize tetrachloroethylene. Int. Arch. Occup. Environ. Health 51(4):381-390.

Okawa, M.T., and A. Bodner. 1973. Health Hazard Evaluation Report, Western Electric Company, Dublin, California. Report No. HHE 72-74-51. Hazard Evaluation Services Branch, National Institute for Occupational Health and Safety and Health, U.S. Department of Health, Education and Welfare, Cincinnati, OH.

Okino, T., T. Nakajima, and M. Nakano. 1991. Morphological and biochemical analyses of trichloroethylene hepatotoxicity: Differences in ethanol- and phenobarbital-pretreated rats. Toxicol. Appl. Pharmacol. 108(3):379-389.

Olshan, A.F., M.C. Weissler, M.A. Watson, and D.A. Bell. 2001. Risk of head and neck cancer and the alcohol dehydrogenase 3 genotype. Carcinogenesis 22(1):57-61.

OMB (Office of Management and Budget). 2006. Proposed Risk Assessment Bulletin. Released January 9, 2006. Washington, DC: Office of Management and Budget, Executive Office of the President.

OMIM (Online Mendelian Inheritance in Man). 2006a. Cytochrome P450, Subfamily IIIA, Polypeptide 5; CYP3A5. MIM 605325. National Center for Biotechnology Information [online]. Available: http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=605325 [accessed May 4, 2006].

OMIM (Online Mendelian Inheritance in Man). 2006b. Cytochrome P450, Subfamily IIE; CYP2E. MIM 124040. National Center for Biotechnology Information [online]. Available: http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=124040 [accessed May 4, 2006].

Oshiro, W.M., Q.T. Krantz, and P.J. Bushnell. 2001. Characterizing tolerance to trichloroethylene (TCE): Effects of repeated inhalation of TCE on performance of a signal detection task in rats. Neurotoxicol. Teratol. 23(6):617-628.

Oshiro, W.M., Q.T. Krantz, and P.J. Bushnell. 2004. A search for residual behavioral effects of trichloroethylene (TCE) in rats exposed as young adults. Neurotoxicol. Teratol. 26(2):239-251.

Ou, J., Z. Ou, D.G. McCarver, R.N. Hines, K.T. Oldham, A.W. Ackerman, and K.A. Pritchard, Jr. 2003. Trichloroethylene decreases heat shock protein 90 interactions with endothelial nitric oxide synthase: Implications for endothelial cell proliferation. Toxicol. Sci. 73(1):90-97.

Pähler, A., J. Parker, and W. Dekant. 1999. Dose-dependent protein adduct formation in kidney, liver, and blood of rats and in human blood after perchloroethene inhalation. Toxicol. Sci. 48(1):5-13.

Palmer, K.C. 1985. Clara cell adenomas of the mouse lung. Interaction with alveolar type 2 cells. Am. J. Pathol. 120(3):455-463.

Pandey, J.P. 2004. Trichloroethylene exposure and host genetic factors in scleroderma. Pp. 80-86 in Trichloroethylene: The Scientific Basis of Risk Assessment, L.C. Mohr, D.G. Hoel, and D. Jollow, eds. Charleston, SC: The Medical University of South Carolina Press.

Pandey, J.P., and F. Takeuchi. 1999. TNF-alpha and TNF-beta gene polymorphisms in systemic sclerosis. Hum. Immunol. 60(11):1128-1130.

Pandey, J.P., G.P. Page, R.M. Silver, E.C. LeRoy, and C.A. Bona. 2001. Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted. Exp. Clin. Immunogenet. 18(3):123-129.

Pannett, B., D. Coggon, and E.D. Acheson. 1985. A job-exposure matrix for use in population based studies in England and Wales. Br. J. Ind. Med. 42(11):777-783.

Pantucharoensri, S., P. Boontee, P. Likhitsan, C. Padungtod, and S. Prasartsansoui. 2004. Generalized eruption accompanied by hepatitis in two Thai metal cleaners exposed to trichloroethylene. Ind. Health 42(3):385-388.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Parent, M.E., Y. Hua, and J. Siemiatycki. 2000. Occupational risk factors for renal cell carcinoma in Montreal. Am. J. Ind. Med. 38(6):609-618.

Park, M.K., T. Ludden, K.V. Arom, J. Rogers, and J.D. Oswalt. 1982. Myocardial vs serum digoxin concentrations in infants and adults. Am. J. Dis. Child 136(5):418-420.

Park, P.A., M.I. Gilmour, and M.J. Selgrade. 1993. Pulmonary effects to streptococcal infection following acute exposure to trichloroethylene (TCE) or chloroform (CHCl3). Toxicologist 13:107.

Park, S.B., J.D. Osterloh, S. Vamvakas, M. Hashmi, M.W. Anders, and J.R. Cashman. 1992. Flavin-containing monooxygenase-dependent stereoselective S-oxygenation and cytotoxicity of cysteine S-conjugates and mercapturates. Chem. Res. Toxicol. 5(2):193-201.

Partanen, T., P. Heikkila, S. Hernberg, T. Kauppinen, G. Moneta, and A. Ojajarvi. 1991. Renal cell cancer and occupational exposure to chemical agents. Scand. J. Work Environ. Health 17(4):231-239.

Pastino, G.M., W.Y. Yap, and M. Carroquino. 2000. Human variability and susceptibility to trichloroethylene. Environ. Health Perspect. 108(Suppl. 2):201-214.

PCCRARM (Presidential/Congressional Commission on Risk Assessment and Risk Management). 1997. Risk Assessment and Risk Management in Regulatory Decision-Making, Vol. 2. Washington, DC: U.S. General Printing Office [online]. Available: http://www.riskworld.com/Nreports/1997/risk-rpt/volume2/pdf/v2epa.PDF [accessed July 12, 2006].

Pelekis, M., L.A. Gephart, and S.E. Lerman. 2001. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds. Regul. Toxicol. Pharmacol. 33(1):12-20.

Pereira, M.A. 1996. Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. Fundam. Appl. Toxicol. 31(2):192-199.

Pereira, M.A., and J.B. Phelps. 1996. Promotion by dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. Cancer Lett. 102(1-2):133-141.

Pereira, M.A., K. Li, and P.M. Kramer. 1997. Promotion by mixtures of dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. Cancer Lett. 115(1):15-23.

Pereira, M.A., P.M. Kramer, P.B. Conran, and L. Tao. 2001. Effect of chloroform on dichloroacetic acid and trichloroacetic acid-induced hypomethylation and expression of the c-myc gene and on their promotion of liver and kidney tumors in mice. Carcinogenesis 22(9):1511-1519.

Pereira, M.A., W. Wang, P.M. Kramer, and L. Tao. 2004. Prevention by methionine of dichloroacetic acid-induced liver cancer and DNA hypomethylation in mice. Toxicol. Sci. 77(2):243-248.

Pesch, B., J. Haerting, U. Ranft, A. Klimpel, B. Oelschlagel, W. Schill, and MURC Study Group. 2000a. Occupational risk factors for renal cell carcinoma: Agent-specific results from a case-control study in Germany. Int. J. Epidemiol. 29(6):1014-1024.

Pesch, B., J. Haerting, U. Ranft, A. Klimpel, B. Oelschlagel, and W. Schill. 2000b. Occupational risk factors for urothelial carcinoma: Agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter Urothelial and Renal Cancer. Int. J. Epidemiol. 29(2):238-247.

Pessayre, D., H. Allemand, J.C. Wandscheer, V. Descatoire, J.Y. Artigou, and J.P. Benhamou. 1979. Inhibition, activation, destruction and induction of drug metabolizing enzymes by trichloroethylene. Toxicol. Appl. Pharmacol. 49(2):355-363.

Pessayre, D., B. Cobert, V. Descatoire, C. Degott, G. Babany, C. Funchk-Brentano, M. Delaforge, and D. Larrey. 1982. Hepatotoxicity of trichloroethylene-carbon tetrachloride mixtures in rats. A possible consequence of the potentiation by trichloroethylene of

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

carbon tetrachloride-induced lipid peroxidation and liver lesions. Gastroenterology 83(4):761-772.

Peters, F.M., S. Preston-Martin, and M.C. Yu. 1981. Brain tumors in children and occupational exposure of parents. Science 213(4504):235-237.

Peters, J.M., D.H. Garabrant, W.E. Wright, L. Bernstein, and T.M. Mack. 1985. Uses of a cancer registry in the assessment of occupational cancer risks. Natl. Cancer Inst. Monogr. 69:157-161.

Petitti, D.B. 1994. Of babies and bathwater. Am. J. Epidemiol. 140(9):779-782.

Peto, R. 1978. Carcinogenic effects of chronic exposure to very low levels of toxic substances. Environ. Health Perspect. 22:155-159.

Phoon, W.H., M.O. Chan, V.S. Rajan, K.J. Tan, T. Thirumoorthy, and C.L. Goh. 1984. StevensJohnson syndrome associated with occupational exposure to trichloroethylene. Contact Dermatitis 10(5):270-276.

Pikkarainen, P.H., and N.C. Raiha. 1967. Development of alcohol dehydrogenase activity in the human liver. Pediatr. Res. 1(3):165-168.

Poet, T.S., R.A. Corley, K.D. Thrall, J.A. Edwards, H. Tanojo, K.K. Weitz, X. Hui, H.I. Maibach, and R.C. Wester. 2000. Assessment of the percutaneous absorption of trichloroethylene in rats and humans using MS/MS real-time breath analysis and physiologically based pharmacokinetic modeling. Toxicol. Sci. 56(1):61-72.

Poon, R., J. Nakai, A. Yagminas, F. Benoit, D. Moir, I. Chu, and V.E. Valli. 2002. Subchronic toxicity of chloral hydrate on rats: A drinking water study. J. Appl. Toxicol. 22(4):227-236.

Popp, W., D. Rauscher, and G. Muller. 1994. Concentrations of benzene in blood and S-phenylmercapturic and t-t-muconic acid in urine in car mechanics. Int. Arch. Occup. Environ. Health 66(1):1-6.

Poulin, P., and K. Krishnan. 1996. A tissue composition-based algorithm for predicting tissue: Air partition coefficients of organic chemicals. Toxicol. Appl. Pharmacol. 136(1): 126-130.

Povey, A., M.J. Guppy, M. Wood, C. Knight, C.M. Black, and A.J. Silman. 2001. Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents. Arthritis Rheum. 44(3):662-665.

Pravecek, T.L., S.R. Channel, W.J. Schmidt, and J.K. Kidney. 1996. Cytotoxicity and metabolism of dichloroacetic acid and trichloroacetic acid in B6C3F1 mouse liver tissue. In Vitro Toxicol. 9(3):261-269.

Prout, M.S., W.M. Provan, and T. Green. 1985. Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice. Toxicol. Appl. Pharmacol. 79(3):389-400.

Quattrin, T., C.H. Albini, B.J. Mills, and M.H. MacGillivray. 1990. Comparison of urinary growth hormone and IGF-I excretion in small- and appropriate-for-gestational-age infants and healthy children. Pediatr Res. 28(3):209-212.

Quinn, M.M., T.J. Smith, A.O., Youk, G.M. Marsh, R.A. Stone, J.M. Buchanich, and M.J. Gula. 2001. Historical cohort study of US man-made vitreous fiber production workers: VIII. Exposure-specific job analysis. J. Occup. Environ. Med. 43(9):824-834.

Raascchou-Nielsen, O., J. Hansen, B.L. Thomsen, I. Johansen, L. Lipworth, J.K. McLaughlin, and J.H. Olsen. 2002. Exposure of Danish workers to trichloroethylene, 1947-1989. Appl. Occup. Environ. Hyg. 17(10):693-703.

Raaschou-Nielsen, O., J. Hansen, J.K. McLaughlin, H. Kolstad, J.M. Christensen, R.E. Tarone, and J.H. Olsen. 2003. Cancer risk among workers at Danish companies using trichloroethylene: A cohort study. Am. J. Epidemiol. 158(12):1182-1192.

Rajan, N., R. Rahim, and S. Krishna Kumar. 1985. Formic acid poisoning with suicidal intent: A report of 53 cases. Postgrad. Med. J. 61(711):35-36.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Ramsdell, A.F., and R.R. Markwald. 1997. Induction of endocardial cushion tissue in the avian heart is regulated, in part, by TGFbeta-3-mediated autocrine signaling. Dev. Biol. 188(1):64-74.

Rasmussen, K., S. Sabroe, M. Wohloert, H.J. Ingerslev, B. Kappel, and J. Nielsen. 1988. A genotoxic study of male workers exposed to trichloroethylene. Sperm parameters and chromosomic aberrations in lymphocytes. Int. Arch. Occup. Environ. Health 60(6):419-423.

Rasmussen, K., P. Arlien-Soborg, and S. Sabroe. 1993. Clinical neurological findings among metal degreasers exposed to chlorinated solvents. Acta Neurol. Scand. 87(3):200-204.

Rasmussen, R.E., D.H. Do, T.S. Kim, and L.C. Dearden. 1986. Comparative cytotoxicity of naphthalene and its monomethyl and mononitro derivatives in the mouse lung. J. Appl. Toxicol. 6(1):13-20.

Rastegar, M., F.P. Lemaigre, and G.G. Rousseau. 2000. Control of gene expression by growth hormone in liver: Key role of a network of transcription factors. Mol. Cell Endocrinol. 164(1-2):1-4.

Raunio, H., J. Hakkola, J. Hukkanen, O. Pelkonen, R. Edwards, A. Boobis, and S. Anttila. 1998. Expression of xenobiotic metabolizing cytochrome P450s in human pulmonary tissue. Arch. Toxicol. Suppl. 20:465-469.

Rebert, C.S., V.L. Day, M.J. Matteucci, and G.T. Pryor. 1991. Sensory-evoked potentials in rats chronically exposed to trichloroethylene: Predominant auditory dysfunction. Neurotoxicol. Teratol. 13(1):83-90.

Rebert, C.S., W.K. Boyes, G.T. Pryor, D.J. Svensgaard, K.M. Kassay, G.R. Gordon, and N. Shinsky. 1993. Combined effects of solvents on the rat’s auditory system: Styrene and trichloroethylene. Int. J. Psychophysiol. 14(1):49-59.

Reddy, J.K., and N.D. Lalwai. 1983. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12(1):1-58.

Reddy, J.K., S. Rao, and D.E. Moody. 1976. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res. 36(4):1211-1217.

Redmond, G.P., J.J. Bell, and J.M. Perel. 1978. Effect of human growth hormone on amobarbital metabolism in children. Clin. Pharmacol. Ther. 24(2):213-218.

Rehm, S., W. Lijinsky, G. Singh, and S. L. Katyal. 1991. Mouse bronchiolar cell carcinogenesis. Histologic characterization and expression of Clara cell antigen in lesions induced by Nnitrosobis-(2-chloroethyl) ureas. Am. J. Pathol. 139(2):413-422.

Reif, J.S., J.B. Burch, J.R. Nuckols, L. Metzger, D. Ellington, and W.K. Anger. 2003. Neurobehavioral effects of exposure to trichloroethylene through a municipal water supply. Environ. Res. 93(3):248-258.

Reiter, R.E., P. Anglard, S. Liu, J.R. Gnarra, and W.M. Linehan. 1993. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res. 53(13):3092-3097.

Reynolds, E.S., and M.T. Moslen. 1977. Halothane hepatotoxicity: Enhancement by polychlorinated biphenyl pretreatment. Anesthesiology 47(1):19-27.

Reznik-Schuller, H. 1976. Ultrastructural alterations of nonciliated cells after nitrosamine treatment and their significance for pulmonary carcinogenesis. Am. J. Pathol. 85(3): 549-552.

Rhomberg, L.R. 2000. Dose-response analysis of the carcinogenic effects of trichloroethylene in experimental animals. Environ. Health Perspect. 108(Suppl. 2):343-358.

Rhomberg, L. 2002. The a posteriori probability of a kidney cancer cluster attributed to trichloroethylene exposure [letter]. Environ. Health Perspect. 110(5):A232.

Richard, A.M., and E.S. Hunter, III. 1996. Quantitative structure-activity relationships for the

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

developmental toxicity of haloacetic acids in mammalian whole embryo culture. Teratology 53(6):352-360.

Riederer, P., P. Foley, G. Bringmann, D. Feineis, R. Bruckner, and M. Gerlach. 2002. Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-ß-carboline: A biologically relevant neurotoxin? Eur. J. Pharmacol. 442(1-2):1-16.

Rijhsinghani, K.S., C. Abrahams, M.A. Swerdlow, K.V. Rao, and T. Ghose. 1986. Induction of neoplastic lesions in the livers of C57BL x C3HF1 mice by chloral hydrate. Cancer Detect. Prev. 9(3-4):279-288.

Ripp, S.L., L.H. Overby, R.M. Philpot, and A.A. Elfarra. 1997. Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing mono-oxygenases: Studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine. Mol. Pharmacol. 51(3):507-515.

Ritz, B. 1999. Cancer mortality among workers exposed to chemicals during uranium processing. J. Occup. Environ. Med. 41(7):556-66.

Robbiano, L., D. Baroni, R. Carrozzino, E. Mereto, and G. Brambilla. 2004. DNA damage and micronuclei induced in rat and human kidney cells by six chemicals carcinogenic to the rat kidney. Toxicology 204(2-3):187-195.

Robert, C.P. 2004. Discussion of the two papers read at the society half-day in inverse problems on December 10th, 2003. Discussion on the meeting on “Statistical Approaches to Inverse Problems” J. R. Stat. Soc. B 66(3):630-633 [online]. Available: http://www.ceremade.dauphine.fr/%7Exian/RSS1203.pdf [accessed March 31, 2006].

Robins, J.M. 1986. A new approach to causal interference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect. Math. Modeling 7:1393-1512.

Robins, J.M. 1987a. Errata to “A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect”. Comput. Math. Appl. 14(9-12):917-921.

Robins, J.M. 1987b. Addendum to “A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect”. Comput. Math. Appl. 14(9-12):923-945.

Robins, J.M. 1987c. A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. J. Chron. Dis. 40(Suppl. 2):139S-161S.

Rodenbeck, S.E., L.M. Sanderson, and A. Rene. 2000. Maternal exposure to trichloroethylene in drinking water and birth-weight outcomes. Arch. Environ. Health 55(3):188-194.

Rose, S.R., G. Municchi, K.M. Barnes, G.A. Kamp, M.M. Uriarte, J.L. Ross, F. Cassorla, and G.B. Cutler, Jr. 1991. Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J. Clin. Endocrinol. Metab. 73(2):428-435.

Rosner, E., and W. Dekant. 1999. Stereoselective formation of glutathione S-conjugates from halovinylmercapturate sulphoxides. Xenobiotica 29(4):327-340.

Rosner, E., M. Muller, and W. Dekant. 1998. Stereo- and regioselective conjugation of Shalovinyl mercapturic acid sulfoxides by glutathione S-transferases. Chem. Res. Toxicol. 11(2):12-18.

Rothman, K.J., and S. Greenland. 1998. Modern Epidemiology, 2nd Ed. New York: Lippincott– Raven.

Ruijten, M.W., M.M. Verberk, and H.J. Salle. 1991. Nerve function in workers with long term exposure to trichloroethylene. Br. J. Ind. Med. 48(2):87-92.

Rutter, N. 1987. Percutaneous drug absorption in the newborn: Hazards and uses. Clin. Perinatol. 14(4):911-930.

Rylander, L., U. Stromberg, and L. Hagmar. 1995. Decreased birthweight among infants born

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

to women with a high dietary intake of fish contaminated with persistent organochlorine compounds. Scand. J. Work Environ. Health 21(5):368-375.

Sabel, G.V., and T.P. Clark. 1984. Volatile organic compounds as indicators of municipal solid waste leachate contamination. Waste Manage. Res. 2:119-130 (as cited in EPA 2001a).

Saghir, S.A., and I.R. Schultz. 2002. Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naïve and GST-zeta-depleted rats. Environ. Health Perspect. 110(8):757-763.

Saihan, E.M., J.L. Burton, and K.W. Heaton. 1978. A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud’s phenomenon and peripheral neuropathy. Br. J. Dermatol. 99(4):437-440.

Saillenfait, A.M., I. Langonne, and J.P. Sabate. 1995. Developmental toxicity of trichloroethylene, tetrachloroethylene and four of their metabolites in rat whole embryo culture. Arch. Toxicol. 70(2):71-82.

Salmon, A.G., K.W. Kizer, L. Zeise, R.J. Jackson, and M.T. Smith. 1995. Potential carcinogenicity of chloral hydrate—a review. J. Toxicol. Clin. Toxicol. 33(2):115-121.

SAMHSA (Substance Abuse and Mental Health Services Administration). 2003. Overview of Findings from the 2002 National Survey on Drug Use and Health. NHSDA Series H-21. DHHS SMA 03–3774. Office of Applied Studies, Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services, Rockville, MD. September 2003 [online]. Available: http://www.oas.samhsa.gov/nhsda/2k2nsduh/Overview/2k2Overview.htm [accessed March 31, 2006].

Sanchez, I.M., and R.J. Bull. 1990. Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate. Toxicology 64(1): 33-46.

Sanders, V.M., A.N. Tucker, K.L. White, Jr., B.M. Kauffmann, P. Hallett, R.A. Carchman, J.F. Borzelleca, and A.E. Munson. 1982. Humoral and cell-mediated immune status in mice exposed to trichloroethylene in the drinking water. Toxicol. Appl. Pharmacol. 62(3):358-368.

Sapkota, A., D. Williams, and T.J. Buckley. 2005. Tollbooth workers and mobile source-related hazardous air pollutants: How protective is the indoor environment? Environ. Sci. Technol. 39(9):2936-2943.

Sato, A. 1993. Confounding factors in biological monitoring of exposure to organic solvents. Int. Arch. Occup. Environ. Health 65(suppl. 1):S61-S67.

Sato, A., and T. Nakajima. 1985. Enhanced metabolism of volatile hydrocarbons in rat liver following food deprivation, restricted carbohydrate intake, and administration of ethanol, phenobarbitol, polychlorinated biphenyl and 3-methylcholanthrene: A comparative study. Xenobiotica 15(1):67-75.

Sato, A., T. Nakajima, Y. Fujiwara, and N. Murayama. 1977. A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. Br. J. Ind. Med. 34(1):55-63.

Sato, A., T. Nakajima, and Y. Koyama. 1983. Interaction between ethanol and carbohydrate on the metabolism in rat liver of aromatic and chlorinated hydrocarbons. Toxicol. Appl. Pharmacol. 68(2):242-249.

Sato, A., K. Endoh, T. Kaneko, and G. Johanson. 1991. A simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent vapours. Br. J. Ind. Med. 48(5):342-347.

Sato, T., and S.L. Kauffman. 1980. A scanning electron microscope study of the type II and Clara cell adenoma of the mouse lung. Lab. Invest. 43(1):28-36.

Sausen, P.J., and A.A. Elfarra. 1991. Reactivity of cysteine S-conjugate sulfoxides: Formation of S-[1-chloro-2-(S-glutathionyl)vinyl]-L-cysteine sulfoxide by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with glutathione. Chem. Res. Toxicol. 4(6):655-660.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Sausen, P.J., R.J. Duescher, and A.A. Elfarra. 1993. Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes. Mol. Pharmacol. 43(3):388-396.

Scheff, P.A., and R.A. Wadden. 1993. Receptor modeling of volatile organic compounds: 1. Emission inventory and validation. Environ. Sci. Technol. 27(4):617-625.

Schlehofer, B., C. Heuer, M. Blettner, D. Niehoff, and J. Wahrendorf. 1995. Occupation, smoking and demographic factors, and renal cell carcinoma in Germany. Int. J. Epidemiol. 24(1):51-57.

Schultz, I.R., J.L. Merdink, A. Gonzalez-Leon, and R.J. Bull. 2002. Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: Dose-response relationships and age as a modifying factor. Toxicology 173(3):229-247.

Schuz, J., U. Kaletsch, R. Meinert, P. Kaatsch, and J. Michaelis. 2000. Risk of childhood leukemia and parental self-reported occupational exposure to chemicals, dusts, and fumes: Results from pooled analyses of German population-based case-control studies. Cancer Epidemiol. Biomarkers Prev. 9(8):835-838.

Schwetz, B.A., K.J. Leong, and P.J. Gehring. 1975. The effect of maternally inhaled trichloroethylene, perchloroethylene, methyl chloroform, and methylene chloride on embryonal and fetal development in mice and rats. Toxicol. Appl. Pharmacol. 32(1):84-96.

Scott, C.S., and V.J. Cogliano. 2000. Introduction: trichloroethylene health risks—state of the science. Environ. Health Perspect. 108(Suppl. 2):159-160.

Scott, J.E., P.G. Forkert, M. Oulton, M.G. Rasmussen, S. Temple, M.O. Frazer, and S. Whitefield. 1988. Pulmonary toxicity of trichloroethylene: Induction of changes in surfactant phosphor lipids and phospholipase AZ activity in the murine lung. Exp. Mol. Pathol. 49(1):141-150.

SEER (Surveillance, Epidemiology, and End Results Program). 2005. SEER*Stat Databases: Incidence - SEER 13 Regs Public-Use, Nov. 2004 Sub. for Expanded Races (1992-2002) and Incidence - SEER 13 Regs excluding AK Public-Use, Nov. 2004 Sub. for Hispanics (1992-2002). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. April 2005 [online]. Available: http://www.seer.cancer.gov [accessed June 21, 2006].

Seidler, A., E. Raum, B. Arabin, W. Hellenbrand, U. Walter, and F.W. Schwartz. 1999. Maternal occupational exposure to chemical substances and the risk of infants small-for-gestationalage. Am. J. Ind. Med. 36(1):213-222.

Seiji, K., O. Inoue, C. Jin, Y.T. Liu, S.X. Cai, M. Ohashi, T. Watanabe, H. Nakatsuka, T. Kawai, and M. Ikeda. 1989. Dose excretion relationship in tetrachloroethylene exposed-workers and the effect of tetrachloroethylene co-exposure on trichloroethylene metabolism. Am. J. Ind. Med. 16(6):675-684.

Seldén, A., and G. Ahlborg. 1991. Mortality and cancer morbidity after exposure to military aircraft fuel. Aviat. Space Environ. Med. 62(8):789-794.

Self, S.G., and R.H. Mauritsen. 1988. Power/sample size calculations for generalized linear models. Biometrics 44(1):79-86.

Self, S.G., R.H. Mauritsen, and J. Ohara. 1992. Power calculations for likelihood ratio tests in generalized linear models. Biometrics 48(1):31-39.

Sellers , E.M., and J. Koch-Weser. 1970. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate. N. Engl. J. Med. 283(16):827-831.

Sellers, E.M., M. Lang, J. Koch-Weser, E. LeBlanc, and H. Kalant. 1972. Interaction of chloral hydrate and ethanol in man. I. Metabolism. Clin. Pharmacol. Ther. 13(1):37-49.

Sellers, E.M., M. Lang-Sellers, and J. Koch-Weser. 1978. Comparative metabolism of chloral hydrate and trichlofos. J. Clin. Pharmacol. 18(1):457-461.

Sexton, K., J.L. Adgate, G. Ramachandran, G.C. Pratt, S.J. Mongin, T.H. Stock, and M.T.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Morandi. 2004. Comparison of personal, indoor, and outdoor exposures to hazardous air pollutants in three urban communities. Environ. Sci. Technol. 38(2):423-430.

Sexton, K., J.L. Adgate, T.R. Church, D.L. Ashley, L.L. Needham, G. Ramachandran, A.L. Fredrickson, and A.D. Ryan. 2005. Children‘s exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ. Health Perspect. 113(3):342-349.

Shah, J.J., and H.B. Singh. 1988. Distribution of volatile organic chemicals in outdoor and indoor air. Environ. Sci. Technol. 22(12):1381-1388.

Shapiro, S. 1994. Meta-analysis/Shmeta-analysis. Am. J. Epidemiol. 140(9):771-778.

Sharpe, C.R., J.E. Rochon, J.M. Adam, and S. Suissa. 1989. Case-control study of hydrocarbon exposures in patients with renal cell carcinoma. CMAJ 140(11):1309-1318.

Shaw, G.M., L.H. Malcoe, and E. Katz. 1992. Maternal workplace exposures to organic solvents and congenital cardiac anomalies. J. Occup. Med. Toxicol. 1:371-376.

Sheffels, P., J.L. Schroeder, T.G. Altuntas, H.D. Liggitt, and E.D. Kharasch. 2004. Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (“compound A”) in rats. Chem. Res. Toxicol. 17(9):1177-1189.

Sherman, C.D., and C.J. Portier. 1997. The two-stage model of carcinogenesis: Overcoming the nonidentifiability dilemma. Risk Anal. 17(3):367-374.

Shiao, Y.H. 2004. VHL alterations and renal tumorigenesis. Presentation at EPA Symposium on New Scientific Research Related to the Health Effects of TCE, February 26-27, 2004, Washington, DC.

Shiao, Y.H., B.A. Diwan, A.O. Perantoni, R.J. Calvert, B. Zbar, M.I. Lerman, and J.M. Rice. 1997. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers. Mol. Carcinog. 19(4):230-235.

Shiao, Y.H., J.M. Rice, L.M. Anderson, B.A. Diwan, and G.C. Hard. 1998. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J. Natl. Cancer Inst. 90(22):1720-1723.

Shih, C.L., H.H. Chen, and T.H. Chiu. 2001. Acute exposure to trichloroethylene differentially alters the susceptibility to chemoconvulsants in mice. Toxicology 162(1):35-42.

Shimada, T., H. Yamazaki, M. Mimura, Y. Inui, and F.P. Guengerich. 1994. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270(1):414-423.

Shindell, S., and S. Ulrich. 1985. A cohort study of employees of a manufacturing plant using trichloroethylene. J. Occup. Med. 27(8):577-579.

Shu, X.O., P. Stewart, W.Q. Wen, D. Han, J.D. Potter, J.D. Buckley, E. Heineman, and L.L. Robison. 1999. Parental occupational exposure to hydrocarbons and risk of acute lymphocytic leukemia in offspring. Cancer Epidemiol. Biomarkers Prev. 8(9):783-791.

Shultz, J., and H. Weiner. 1979. Alteration of the enzymology of chloral hydrate reduction in the presence of ethanol. Biochem. Pharmacol. 28(23):3379-3384.

Sieber, W.K., Jr., D.S. Sundin, T.M. Frazier, and C.F. Robinson. 1991. Development, use, and availability of a job exposure matrix based on national occupational hazard survey data. Am. J. Ind. Med. 20(2):163-174.

Siemiatycki, J. 1991. Risk Factors for Cancer in the Workplace. Boca Raton, FL: CRC Press.

Siemiatycki, J., N.E. Day, J. Fabry, and J.A. Cooper. 1981. Discovering carcinogens in the occupational environment: A novel epidemiologic approach. J. Natl. Cancer Inst. 66(2):217-225.

Siemiatycki, J., S. Wacholder, L. Richardson, R. Dewar, and M. Gerin. 1987. Discovering car-

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

cinogens in the occupational environment. Methods of data collection and analysis of a large case-referent monitoring system. Scand. J. Work Environ. Health 13(6):486-492.

Simmons, J.E., W.K. Boyes, P.J. Bushnell, J.H. Raymer, T. Limsakun, A. McDonald, Y.M. Sey, and M.V. Evans. 2002. A physiologically based pharmacokinetic model for trichloroethylene in the male Long-Evans rat. Toxicol. Sci. 69(1):3-15.

Sinks, T., B. Lushniak, B.J. Haussler, J. Sniezek, J.F. Deng, P. Roper, P. Dill, and R. Coates. 1992. Renal cell cancer among paperboard printing workers. Epidemiology 3(6):483-489.

Smith, M., D.A. Hopkinson, and H. Harris. 1971. Developmental changes and polymorphism in human alcohol dehydrogenase. Ann. Hum. Genet. 34(3):251-271.

Smith, M.K., J.L. Randall, E.J. Read, and J.A. Stober. 1989. Teratogenic activity of trichloroacetic acid in the rat. Teratology 40(5):445-451.

Smith, M.K., J.L. Randall, E.J. Read, and J.A. Stober. 1992. Developmental toxicity of dichloroacetate in the rat. Teratology 46(3):217-223.

Smith, T.J. 2002. Issues in exposure and dose assessment for epidemiology and risk assessment. Hum. Ecol. Risk Assess. 8(2):1267-1293.

Smith, T.J., P.A. Stewart, and R.F. Herrick. 1995. Retrospective exposure assessment. Pp. 308-323 in Occupational Hygiene, 2nd Ed., J.M. Harrington and K. Gardiner, eds. London: Blackwell Science.

Snow, J. 1856. Cholera and the water supply in the south districts of London, in 1854. J. Public Health San. Rev. 2(Oct.):239-257.

Solus, J.F., B.J. Arietta, J.R. Harris, D.P. Sexton, J.Q. Steward, C. McMunn, P. Ihrie, J.M. Mehall, T.L. Edwards, and E.P. Dawson. 2004. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics 5(7):895-931.

Soni, M.G., R.S. Mangipudy, M.M. Mumtaz, and H.M. Mehendale. 1998. Tissue repair response as a function of dose during trichloroethylene hepatotoxicity. Toxicol. Sci. 42(2):158-165.

Soni, M.G., S.K. Ramaiah, M.M. Mumtaz, H. Clewell, and H.M. Mehendale. 1999. Toxicant-inflicted injury and stimulated tissue repair are opposing toxicodynamic forces in predictive toxicology. Regul. Toxicol. Pharmacol. 29(2 Pt 1):165-174.

Sonnenfeld, N., I. Hertz-Picciotto, and W.E. Kaye. 2001. Tetrachloroethylene in drinking water and birth outcomes at the US Marine Corps Base at Camp Lejeune, North Carolina. Am. J. Epidemiol. 154(1):902-908.

Sorokin, S.P. 1970. The cells of the lung. Pp. 3-43 in Morphology of the Experimental Respiratory Carcinogenesis, P. Nettesheim, M.G. Hanna, and J.W. Deatherage, eds. AEC Symposium Series 21. Oak Ridge TN: U.S. Energy Commission.

Soucek, T., R.S. Yeung, and M. Hengstschlager. 1998. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. USA 95(26):15653-15658.

Spirtas, R., P.A. Stewart, J.S. Lee, D.E. Marano, C.D. Forbes, D.J. Grauman, H.M. Pettigrew, A. Blair, R.N. Hoover, and J.L. Cohen. 1991. Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. Br. J. Ind. Med. 48(8):515-530.

Stauber, A.J., and R.J. Bull. 1997. Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). Toxicol. Appl. Pharmacol. 144(2):235-246.

Stauber, A.J., R.J. Bull, and B.D. Thrall. 1998. Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro. Toxicol. Appl. Pharmacol. 150(2):287-294.

Stayner, L., K. Steenland, M. Dosemeci, and I. Hartz-Picciotto. 2003. Attenuation of exposureresponse curves in occupational cohort studies at high exposures. Scand. J. Work Environ. Health 29(4):317-324.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Steenland, K., J. Deddens, A. Salvan, and L. Stayner. 1996. Negative bias in exposure-response trends in occupational studies: Modeling the healthy workers survivor effect. Am. J. Epidemiol. 143(2):202-210.

Steenland, K., J.A. Deddens, and S. Zhao. 2000. Biases in estimating the effect of cumulative exposure in log-linear models when estimated exposure levels are assigned. Scand. J. Work Environ. Health 26(1):37-43.

Steinberg, A.D. 1993. Should chloral hydrate be banned? Pediatrics 92(3):442-446.

Stemhagen, A., J. Slade, R. Altman, and J. Bill. 1983. Occupational risk factors and liver cancer. A retrospective case-control study of primary liver cancer in New Jersey. Am. J. Epidemiol. 117(4):443-454.

Stenner, R.D., J.L. Merdink, D.K. Stevens, D.L. Springer, and R.J. Bull. 1997. Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of tricholoacetic acid. Metabolites of trichloroethylene. Drug Metab.Dispos. 25(5):529-535.

Stenner, R.D., J.L. Merdink, J.W. Fisher, and R.J. Bull. 1998. Physciologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites. Risk Anal. 18(3):261-269.

Steup, D.R., D. Wiersma, D.A. McMillan, and I.G. Sipes. 1991. Pretreatment with drinking water solutions containing trichloroethylene or chloroform enhances the hepatotoxicity of carbon tetrachloride in Fischer 344 rats. Fundam. Appl. Toxicol. 16(4):798-809.

Steup, D.R., P. Hall, D.A. McMillan, and I.G. Sipes. 1993. Time course of hepatic injury and recovery following coadministration of carbon tetrachloride and trichloroethylene in Fischer-344 rats. Toxicol. Pathol. 21(3):327-334.

Stevens, J.L. 1985. Isolation and characterization of a rat liver enzyme with both cysteine conjugate beta-lyase and kynureninase activity. J. Biol. Chem. 260(13):7945-7950.

Stevens, J.L., J.D. Robbins, and R.A. Byrd. 1986. A purified cysteine conjugate beta-lyase from rat kidney cytosol. Requirement for an alpha-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K. J. Biol. Chem. 261(33):15529-15537.

Stewart, B.W., S.M. Le Mesurier, and A.W. Lykke. 1979. Correlation of the biochemical and morphological changes induced by chemical injury in the lung. Chem.Biol. Interact. 26(3):321-338.

Stewart, P., and M. Dosemeci. 2005. Exposure Estimation in Occupational Epidemiology Studies. Presentation at the Third Meeting on Assessing Human Health Risks of Trichloroethylene, June 9, 2005, Irvine, CA.

Stewart, P.A., J.S. Lee, D.E. Marano, R. Spirtas, C.D. Forbes, and A. Blair. 1991. Retrospective cohort mortality study of workers at an aircraft maintenance facility. II. Exposures and their assessment. Br. J. Ind. Med. 48(8):531-537.

Stewart, P.A., W.F. Stewart, J. Siemiatycki, F.F. Heineman, and M. Dosemeci. 1998. Questionnaires for collecting detailed occupational information for community-based case control studies. Am. Ind. Hyg. Assoc. J. 59(1):39-44.

Stewart, R.D., H.C. Dodd, H.H. Gay, and D.S. Erley. 1970. Experimental human exposure to trichloroethylene. Arch. Environ. Health 20(1):64-71.

Stewart, R.D., C.L. Hake, and J.E. Peterson. 1974. Degreasers’ flush: Dermal response to trichloroethylene and ethanol. Arch. Environ. Health 29(1):1-5.

Stewart, W.F., and P.A. Stewart. 1994. Occupational case-control studies: II. Recommendations for exposure assessment. Am. J. Ind. Med. 26(3):313-326.

Stopps, G.J., and M. McLaughlin. 1967. Psychophysiological testing of human subjects exposed to solvent vapors. Am. Ind. Hyg. Assoc. J. 28(1):43-50.

Strange, R.C., C.G. Faulder, B.A. Davis, R. Hume, J.A. Brown, W. Cotton, and D.A. Hopkinson. 1984. The human glutathione S-transferases: Studies on the tissue distribution

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

and genetic variation of the GST1, GST2 and GST3 isozymes. Ann. Hum. Genet. 48(Pt 1):11-20.

Strange, R.C., A.F. Howie, R. Hume, B. Matharoo, J. Bell, C. Hiley, P. Jones, and G.J. Beckett. 1989. The development expression of alpha-, mu- and pi-class glutathione S-transferases in human liver. Biochim. Biophys. Acta 993(2-3):186-190.

Strange, R.C., B. Matharoo, G.C. Faulder, P. Jones, W. Cotton, J.B. Elder, and M. Deakin. 1991. The human glutathione S-transferases: A case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 12(1):25-28.

Swaen, G.M. 1995. Increased incidence of renal cell tumours in a cohort of cardboard workers exposed to trichloroethylene [letter]. Arch. Toxicol. 70(2):127-128, 131-133.

Swan, S.H., G. Shaw, J.A. Harris, and R.R. Neutra. 1989. Congenital cardiac anomalies in relation to water contamination, Santa Clara County, California, 1981-1983. Am. J. Epidemiol. 129(5):885-893.

Sweet, C.W., and S.J. Vermette. 1992. Toxic volatile organic compounds in urban air in Illinois. Environ. Sci. Technol. 26(1):165-173.

Tao, L., K. Li, P.M. Kramer, and M.A. Pereira. 1996. Loss of heterozygosity on chromosome 6 in dichloroacetic acid and trichloroacetic acid-induced liver tumors in female B6C3F1 mice. Cancer Lett. 108(2):257-261.

Tao, L., R. Ge, M. Xie, P.M. Kramer, and M.A. Pereira. 1999. Effect of trichloroethylene on DNA methylation and expression of early-intermediate protooncogenes in the liver of B6C3F1 mice. J. Biochem. Mol. Toxicol. 13(5):231-237.

Tao, L., S. Yang, M. Xie, P.M. Kramer, and M.A. Pereira. 2000a. Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Cancer Lett. 158(2):185-193.

Tao, L., S. Yang, M. Xie, P.M. Kramer, and M.A. Pereira. 2000b. Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: Prevention by methionine. Toxicol. Sci. 54(2):399-407.

Tao, L., W. Wang, P.M. Kramer, and M.A. Pereira. 2004a. Effect of dibromoacetic acid on DNA methylation, glycogen accumulation, and peroxisome proliferation in mouse and rat liver. Toxicol. Sci. 82(1):62-69.

Tao, L., Y. Li, P.M. Kramer, W. Wang, and M.A. Perieira. 2004b. Hypomethylation of DNA and the insulin-like growth factor-II gene in dichloroacetic and trichloroacetic acid-promoted liver mouse tumors. Toxicology 196(1-2):127-136.

Tao, L., W. Wang, L. Li, P.M. Kramer, and M.A. Pereira. 2005. DNA hypomethylation induced by drinking water disinfection by-products in mouse and rat kidney. Toxicol. Sci. 87(2):344-352.

Taskinen, H., A. Anttila, M.L. Lindbohm, M. Sallmen, and K. Hemminki. 1989. Spontaneous abortions and congenital malformations among the wives of men occupationally exposed to organic solvents. Scand. J. Work Environ. Health 15(5):345-352.

Templin, M.V., J.C. Parker, and R.J. Bull. 1993. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol. Appl. Pharmacol. 123(1):1-8.

Templin, M.V., D.K. Stevens, R.D. Stenner, P.L. Bonate, D. Tuman, and R.J. Bull. 1995. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. J. Toxicol. Environ. Health 44(4):435-447.

Thaete, L.G., and A.M. Malkinson. 1991. Cells of origin of primary pulmonary neoplasms in mice: Morphologic and histochemical studies. Exp. Lung Res. 17(2):219-228.

Thai, S.F., J.W. Allen, A.B. DeAngelo, M.H. George, and J.C. Fuscoe. 2003. Altered gene expression in mouse liver after dichloroacetic acid exposure. Mutat. Res. 543(2):167-180.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Thiele, D.L., E.H. Eigenbrodt, and A.J. Ware. 1982. Cirrhosis after repeated trichloroethylene and 1,1,1-trichloroethane exposure. Gastroenterology 83(4):926-929.

Thomas, D.C. 1987. Use of computer simulation to explore analytical issues in nested case-control studies of cancer involving extended exposures: Methods and preliminary findings. J. Chronic Dis. 40(Suppl. 2):201S-208S.

Thomasson, H.R., H.J. Edenberg, D.W. Crabb, X.L. Mai, R.E., Jerome, T.K. Li, S.P. Wang, Y.T. Lin, R.B. Lu, and S.J. Yin. 1991. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am. J. Hum. Genet. 48(4):677-681.

Thomasson, H.R., J.D. Beard, and T.K. Li. 1995. ADH2 gene polymorphisms are determinants of alcohol pharmacokinetics. Alcohol Clin. Exp. Res. 19(6):1494-1499.

Thrall, K.D., and T.S. Poet. 2000. Determination of biokinetic interactions in chemical mixtures using real-time breath analysis and physiologically based pharmacokinetic modeling. J. Toxicol. Environ. Health A 59(8):653-670.

Tielemans, E., D. Heederik, A. Burdorf, R. Vermeulen, H. Veulemans, H. Kromhout, and K. Hartog. 1999. Assessment of occupational exposures in a general population: Comparison of different methods. Occup. Environ. Med. 56(3):145-151.

Tikkanen, J., and O.P. Heinonen. 1988. Cardiovascular malformations and organic solvent exposure during pregnancy in Finland. Am. J. Ind. Med. 14(1):1-8.

‘t Mannetje, A., K. Steenland, M. Attfield, P. Boffetta, H. Checkoway, N. DeKlerk, and R.S. Koskela. 2002. Exposure-response analysis and risk assessment for silica and silicosis mortality in a pooled analysis of six cohorts. Occup. Environ. Med. 59(11):723-728.

Tola, S., R. Vilhunen, E. Jarvinen, and M.L. Korkala. 1980. A cohort study on workers exposed to trichloroethylene. J. Occup. Med. 22(11):737-740.

Tong, Z., P.G. Board, and M.W. Anders. 1998. Glutathione transferase zeta catalyzes the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem. J. 331(Pt. 2):371-374.

Triebig, G., S. Lehrl, W. Kinzel, H. Erzigkeit, J.V. Galster, and K.H. Schaller. 1977. Psychopathometrical results of follow-up studies of trichloroethylene-exposed persons [in German]. Zentralbl. Bakteriol. 164(4):314-377.

Turkall, R.M., G.A. Skowronski, D.H. Suh, and M.S. Abdel-Rahman. 2003. Effect of a chemical mixture on dermal penetration of arsenic and nickel in male pig in vitro. J. Toxicol. Environ. Health 66(7):647-655.

USAF-EPA (U.S. Air Force-U.S. Environmental Protection Agency). 2004a. Development of a Physiologically-Based Pharmacokinetic Model of Trichloroethylene and Its Metabolites for Use in Risk Assessment. Prepared for U.S. Air Force by U.S. Air Force-U.S. Environmental Protection Agency Trichloroethylene Physiogically-Based Pharmacokinetic Model Workgroup. October 14, 2004 [online]. Available: http://www.tera.org/vera/TCE/TCE%20PBPK%20harmonization%20document.pdf [accessed April 3, 2006].

USAF-EPA (U.S. Air Force-U.S. Environmental Protection Agency Trichloroethylene Physiogically-Based Pharmacokinetic Model Workgroup). 2004b. Report of the Peer Consultation of Harmonized PBPK Model for Trichloroethylene. September 29, 2004 [online]. Available: http://www.tera.org/vera/TCE/TCE%20PBPK%20Peer%20Consultation%20Meeting%20Report%20final.pdf [accessed April 3, 2006].

Vaidya, V.S., K. Shankar, E.A. Lock, T.J. Bucci, and H.M. Mehendale. 2003a. Renal injury and repair following S-1, 2 dichlorovinyl-L-cysteine administration to mice. Toxicol. Appl. Pharmacol. 188(2):110-121.

Vaidya, V.S., K. Shankar, E.A. Lock, T.J. Bucci, and H.M. Mehendale. 2003b. Role of tissue repair in protection from S-(1, 2 dichlorovinyl)-L-cysteine-induced acute renal tubular necrosis in the mouse. Toxicol. Sci. 74(1):215-227.

Vaidya,V.S., K. Shankar, E.A. Lock, D. Dixon, H.M. Mehendale. 2003c.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Molecular mechanisms of renal tissue repair in survival from acute renal tubule necrosis: Role of ERK1/2 pathway. Toxicol. Pathol. 31(6):604-618.

Vamvakas, S., T. Brüning, B. Thomasson, M. Lammert, A. Baumuller, F. Bolt, W. Dekant, G. Birner, D. Henschler, and K. Ulm. 1998. Renal cell cancer correlated with occupational exposure to trichloroethene. J. Cancer Res. Clin. Oncol. 124(7):374-382.

Vanden Heuvel, J.P. 1999a. Peroxisome proliferator-activated receptors: A critical link among fatty acids, gene expression and carcinogenesis. J. Nutr. 129(2S Suppl):575S-580S.

Vanden Heuvel, J.P. 1999b. Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis. Toxicol. Sci. 47(1):1-8.

Vandervort, R., and P.L. Polakoff. 1973. Health Hazard Evaluation Report HHE-72-84-31, Dunham-Bush, Inc., West Hartford, Connecticut. Hazard Evaluation Services Branch, National Institute for Occupational Safety and Health, Cincinnati, OH.

Van Duuren, B.L., B.M. Goldschmidt, G. Loewengart, A.C. Smith, S. Melchionne, I. Seldman, and D. Roth. 1979. Carcinogenicity of halogenated olefinic and aliphatic hydrocarbons in mice. J. Natl. Cancer Inst. 63(6):1433-1439.

van Lieshout, E.M., M.F. Knapen, W.P. Lange, E.A. Steegers, and W.H. Peters. 1998. Localization of glutathione S-transferases alpha and pi in human embryonic tissues at 8 weeks gestational age. Hum. Reprod. 13(5):1380-1386.

van Poppel, G., N. de Vogel, P.J. van Balderen, and F.J. Kok. 1992. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme mu. Carcinogenesis 13(2):303-305.

Vasiliou, V., A. Pappa, and T. Estey. 2004. Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab. Rev. 36(2):279-299.

Veeramachaneni, D.N.R., J.S. Palmer, and R.P. Amann. 2001. Long-term effects on male reproduction of early exposure to common chemical contaminants in drinking water. Hum. Reprod. 16(5):979-987.

Verhave, J.C., R.T. Ganesvoorth, H.L. Hillege, S.J. Bakker, D. De Zeeuw, and P.E. De Jong. 2004. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int. 92(Supl.):S18-S21.

Verma, Y., and S.V. Rana. 2003. Gender differences in the metabolism of benzene, toluene and trichloroethylene in rat with special reference to certain biochemical parameters. J. Environ. Biol. 24(2):135-140.

Viljoen, D.L., L.G. Carr, T.M. Foroud, L. Brooke, M. Ramsay, and T.K. Li. 2001. Alcohol dehydrogenase-2*2 allele is associated with decreased prevalence of fetal alcohol syndrome in the mixed-ancestry population of the Western Cape Province, South Africa. Alcohol Clin. Exp. Res. 25(12):1719-1722.

Volkel, W., and W. Dekant. 1998. Chlorothioketene, the ultimate reactive intermediate formed by cysteine conjugate beta-lyase-mediated cleavage of the trichloroethene metabolite S-(1,2-Dichlorovinyl)-L-cysteine, forms cytosine adducts in organic solvents, but not in aqueous solution. Chem. Res. Toxicol. 11(9):1082-1088.

Volkel, W., M. Friedewald, E. Lederer, A. Pahler, J. Parker, and W. Dekant. 1998. Biotransformation of perchloroethene: Dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L- cysteine in rats and humans after inhalation. Toxicol. Appl. Pharmacol. 153(1):20-27.

Von Tungeln, L.S., P. Yi, T.J. Bucci, V.M. Samokyszyn, M.W. Chou, F.F. Kadlubar, and P.P. Fu. 2002. Tumorigenicity of chloral hydrate, trichloroacetic acid, trichloroethanol, malondialdehyde, 4-hydroxy-2-nonenal, crotonaldehyde, and acrolein in the B6C3F(1) neonatal mouse. Cancer Lett. 185(1):13-19.

Wacholder, S., J.K. McLaughlin, D.T. Silverman, and J.S. Mandel. 1992a. Selection of controls in case-control studies. I. Principles. Am. J. Epidemiol. 135(9):1019-1028.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Wacholder, S., D.T. Silverman, J.K. McLaughlin, and J.S. Mandel. 1992b. Selection of controls in case-control studies. III. Design options. Am. J. Epidemiol. 135(9):1042-1050.

Wakefield, J.C., and N. Rahman. 2000. The combination of population pharmacokinetic studies. Biometrics 56(1):263-270.

Walgren, J.E., D.T. Kurtz, and J.M. McMillan. 2000a. The effect of the trichloroethylene metabolites trichloroacetate and dichloroacetate on peroxisome proliferation and DNA synthesis in cultured human hepatocytes. Cell Biol. Toxicol. 16(4):257-273.

Walgren, J.E., D.T. Kurtz, and J.M. McMillan. 2000b. Expression of PPAR(alpha) in human hepatocytes and activation by trichloroacetate and dichloroacetate. Res. Commun. Mol. Pathol. Pharmacol. 108(1-2):116-132.

Walgren, J.L., D.J. Jollow, and J.M. McMillan. 2004. Induction of peroxisome proliferation in cultured hepatocytes by a series of halogenated acetates. Toxicology 197(3):189-197.

Walker, C. 1998. Molecular genetics of renal carcinogenesis. Toxicol. Pathol. 26(1):113-120.

Walker, C., Y.T. Ahn, J. Everitt, and X. Yuan. 1996. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Mol. Carcinog. 15(2):154-161.

Wallace, L.A., E.D. Pellizzari, T.D. Hartwell, C. Sparacino, R. Whitmore, L. Sheldon, H. Zelon, and R. Perritt. 1987. The TEAM (Total Exposure Assessment Methodology) Study: Personal exposures to toxic substances in air, drinking water, and breath of 400 residents of New Jersey, North Carolina, and North Dakota. Environ. Res. 43(2):290-307.

Waller, P.A., D. Clauw, T. Cupps, J.S. Metcalf, R.M. Silver, and E.C. Leroy. 1994. Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene). J. Rheumatol. 21(8):1567-1570.

Wang, F.I., M.L. Kuo, C.T. Shun, Y.C. Ma, J.D. Wang, and T.H. Ueng. 2002. Chronic toxicity of a mixture of chlorinated alkanes and alkenes in ICR mice. J. Toxicol. Environ. Health A 65(3-4):279-291.

Wang, G.F., and N.H. Stacey. 1990. Elevation of individual serum bile acids on exposure to trichloroethylene or alpha-naphthylisothiocyanate. Toxicol. Appl. Pharmacol. 105(2): 209-215.

Wang, J.L., W.L. Chen, S.Y. Tsai, P.Y. Sung, and R.N. Huang. 2001. An in vitro model for evaluation of vaporous toxicity of trichloroethylene and tetrachloroethylene to CHO-K1 cells. Chem. Biol. Interact. 137(2):139-154.

Wang, R.S., T. Nakajima, and T. Honma. 1999. Trichloroethylene inhibits aldehyde dehydrogenase only for aliphatic aldehydes of short chains in rats. Toxicology 132(1):9-18.

Wang, X., and A.A. Abdel-Rahman. 2005. Effect of chronic ethanol administration on hepatic eNOS activity and its association with caveolin-1 and calmodulin in female rats. Am. J. Physiol. Gastrointest. Liver Physiol. 289(3):G579-G585.

Warren, K.R., and T.K. Li. 2005. Genetic polymorphisms: Impact on the risk of fetal alcohol spectrum disorders. Birth Defects Res. A Clin. Mol. Teratol 73(4):195-203.

Wartenberg, D., D. Reyner, and C.S. Scott. 2000. Trichloroethylene and cancer: Epidemiologic evidence. Environ. Health Perspect. 108(Suppl. 2):161-176.

Waseem, M., M. Ali, S. Dogra, K.K. Dutta, and J.L. Kaw. 2001. Toxicity of trichloroethylene following inhalation and drinking contaminated water. J. Appl. Toxicol. 21(6):441-444.

Watanabe, M., T. Takano, and K. Nakamura. 1998. Effect of ethanol on the metabolism of trichloroethylene in the perfused rat liver. J. Toxicol. Environ. Health A 55(4):297-305.

Watanabe, S., and T. Fukui. 2000. Suppressive effect of curcumin on trichloroethylene-induced oxidative stress. J. Nutr. Sci. Vitaminol. (Tokyo) 46(5):230-234.

Waxman, D.J. 1999. P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369(1):11-23.

Weiss, B., and D.A. Cory-Slechta. 2001. Assessment of behavioral toxicity. Pp. 1451-1528 in Principles and Methods of Toxicology, 4th Ed., A.W. Hayes, ed. Philadelphia, PA: Taylor & Francis.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

Werner, M., G. Birner, and W. Dekant. 1995a. The role of cytochrome P4503A1/2 in the sexspecific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)- L-cysteine in rats. Drug Metab. Dispos. 23(8):861-868.

Werner, M., Z.Y.Guo, G. Birner, W. Dekant, and F.P. Guengerich. 1995b. The sulfoxidation of the hexachlorobutadiene metabolite N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)L-cysteine is catalyzed by human cytochrome P450 3A enzymes. Chem. Res. Toxicol. 8(7):917-923.

Werner, M., G. Birner, and W. Dekant. 1996. Sulfoxidation of mercapturic acids derived from tri- and tetrachloroethene by cytochromes P450 3A: A bioactivation reaction in addition to deacetylation and cysteine conjugate beta-lyase mediated cleavage. Chem. Res. Toxicol. 9(1):41-49.

West, D.P., S. Worobec, and L.M. Solomon. 1981. Pharmacology and toxicology of infant skin. J. Invest. Dermatol. 76(3):147-150.

Wheeler, C.W., S.A. Wrighton, and T.M. Guenthner. 1992. Detection of human cytochrome P450 that are immunochemically related to the cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol. 44(1):183-186.

White, K.L., D.W. David, L.F. Butterworth, and P.C. Klykken. 2000. Assessment of autoimmunity-inducing potential using the brown Norway rat challenge model. Toxicol. Lett. 112-113:443-451.

White, R.F., R.G. Feldman, I.I. Eviator, J.F. Jabre, and C.A. Niles. 1997. Hazardous waste and neurobehavioral effects: A developmental perspective. Environ. Res. 73(1-2):113-124.

Wilcosky, T.C., H. Checkoway, E.G. Marshall, and H.A. Tyroler. 1984. Cancer mortality and solvent exposures in the rubber industry. Am. Ind. Hyg. Assoc. J. 45(12):809-811.

Willey, J.C., E. Coy, C. Brolly, M.J. Uteli, M.W. Frampton, J. Hammersley, W.G. Thilly, D. Olson, and K. Cairns. 1996. Xenobiotic metabolism enzyme gene expression in bronchial and alveolar macrophage cells. Am. J. Resp. Cell Mol. Biol. 14(3):262-271.

Windham, G.C., D. Shusterman, S.H. Swan, L. Fenster, and B. Eskenazi. 1991. Exposure to organic solvents and adverse pregnancy outcome. Am. J. Ind. Med. 20(2):241-259.

Wong, O. and P. Decoufle. 1982. Methodological issues involving the standardized mortality ratio and proportionate mortality ratio in occupational studies. J. Occup. Med. 24(4):299-304.

Wong, O., and R. Morgan. 1990. Historical Prospective Mortality Study of Hughes Aircraft Employees at Air Force Plant #44. Final Report. 4700-042-001. Alameda, CA: ENSR Health Sciences.

Wrensch, M., S. Swan, J. Lipscomb, D. Epstein, L. Fenster, K. Claxton, P.J. Murphy, D. Shusterman, and R. Neutra. 1990a. Pregnancy outcomes in women potentially exposed to solvent-contaminated drinking water in San Jose, California. Am. J. Epidemiol. 131(2):283-300.

Wrensch, M., S. Swan, P.J. Murphy, J. Lipscomb, K. Claxton, D. Epstein, and R. Neutra. 1990b. Hydrogeologic assessment of exposure to solvent-contaminated drinking water: Pregnancy outcomes in relation to exposure. Arch. Environ. Health 45(4):210-216.

Wright, P.F., W.D. Thomas, and N.H. Stacey. 1991. Effects of trichloroethylene on hepatic and splenic lymphocytotoxic activities in rodents. Toxicology 70(2):231-242.

Wrighton, S.A., and J.C. Stevens. 1992. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22(1):1-21.

Wu, C., and J. Schaum. 2000. Exposure assessment of trichloroethylene. Environ Health Perspect 108(suppl. 2):359-358.

Xu., H., N. Tanphaichitr, P.G. Forkert, A. Anupriwan, W. Weerachatyanukul, R. Vincent, A. Leader, and M.G. Wade. 2004. Exposure to trichloroethylene and its metabolites causes impairment of sperm fertilizing ability in mice. Toxicol. Sci. 82(2):590-597.

Yang, M., B.F. Coles, R. Delongchamp, N.P. Lang, and F.F. Kadlubar. 2002. Effects of the

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissue. Lung Cancer 38(1):15-21.

Yang, S.P., and G.M. Raner. 2005. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. Toxicol. Appl. Pharmacol. 202(2):140-150.

Yauck, J.S., M.E. Malloy, K. Blair, P.M. Simpson, and D.G. McCarver. 2004. Proximity of residence to trichloroethylene-emitting sites and increased risk of offspring congenital heart defects among older women. Birth Defects Res. A. Clin. Mol. Teratol 70(10):808-814.

Yeldandi, A.V., M.S. Rao, and J.K. Reddy. 2000. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 448(2):159-177.

Yokoyama, A., T. Muramatsu, T. Omori, T. Yokoyama, S. Matsushita, S. Higuchi, K. Maruyama, and H. Ishii. 2001. Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 22(3):433-439.

Youssef, J.A, and M.Z. Badr. 2002. Enhanced hepatocarcinogenicity due to agonists of peroxisome proliferator-activated receptors in senescent rats: Role of peroxisome proliferation, cell proliferation, and apoptosis. Sci. World J. 2:1491-1500.

Youssef, J.A., and M.Z. Badr. 2005. Aging and enhanced hepatocarcinogenicity by peroxisome proliferator-activated receptor alpha agonists. Ageing Res. Rev. 4(1):103-118.

Yu, S., S. Rao, and J.K. Reddy. 2003. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr. Mol. Med. 3(6):561-572.

Zandi-Nejad, K., A.A. Eddy, R.J. Glassock, and B.M. Brenner. 2004. Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int. 92(Supl.):S76-S89.

Zenick, H., K. Blackburn, E. Hope, N. Richdale, and M.K. Smith. 1984. Effects of trichloroethylene exposure on male reproductive function in rats. Toxicology 31(3-4):237-250.

Zhang, G.H., and J.L. Stevens. 1989. Transport and activation of S-(1.2-dichlorovinyl)-Lcysteine and N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine in rat kidney proximal tubules. Toxicol. Appl. Pharmacol. 100(1):51-61.

Zhao, C.Y., and L.L. Jiang. 2003. Peroxisome proliferator-activated receptor in liver diseases [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 11(6):382-384.

Zhao, Y., A. Krishnadasan, N. Kennedy, H. Morganstern, and B. Ritz. 2005. Estimated effects of solvents and mineral oils on cancer incidence and mortality in a cohort of aerospace workers. Am. J. Ind. Med. 48(4):249-258.

Zhu, J., R. Newhook, L. Marro, and C.C. Chan. 2005. Selected volatile organic compounds in residential air in the city of Ottawa, Canada. Environ. Sci. Technol. 39(11):3964-3971.

Zielinska, B., E. Fujita, J. Sagebiel, G. Harshfield, E. Uberna, T. Hayes, and F. Keene. 1998. Arizona Hazardous Air Pollutants Monitoring Program. J.Air Waste Manage. Assoc. 48(11):1038-1050.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×

This page intentionally left blank.

Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 329
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 330
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 331
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 332
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 333
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 334
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 335
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 336
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 337
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 338
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 339
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 340
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 341
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 342
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 343
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 344
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 345
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 346
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 347
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 348
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 349
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 350
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 351
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 352
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 353
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 354
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 355
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 356
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 357
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 358
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 359
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 360
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 361
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 362
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 363
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 364
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 365
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 366
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 367
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 368
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 369
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 370
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 371
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 372
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 373
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 374
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 375
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 376
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 377
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 378
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 379
Suggested Citation:"References." National Research Council. 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues. Washington, DC: The National Academies Press. doi: 10.17226/11707.
×
Page 380
Next: Appendix A Biographic Information on the Committee on Human Health Risks of Trichloroethylene »
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Get This Book
×
Buy Paperback | $90.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Trichloroethylene is a chlorinated solvent widely used as a degreasing agent in industrial and manufacturing settings. It is also used as a chemical intermediate in making other chemicals and is a component of products such as typewriter correction fluid, paint removers, adhesives, and spot removers. In 2001, EPA issued a draft health risk assessment and proposed exposure standards for trichloroethylene. PA's Scientific Advisory Board (SAB) reviewed the draft and it was issued for public comment. A number of scientific issues were raised during the course of these reviews.

Assessing the Human Health Risks of Trichloroethylene identifies and assesses the key scientific issues relevant to analyzing the human health risks of trichloroethylene, considering pertinent toxicologic, epidemiologic, population susceptibility, and other available information, including relevant published scientific literature, EPA's 2001 draft health risk assessment of trichloroethylene, scientific and technical comments received by EPA from public and private sources, and additional relevant information to be provided by the sponsoring agencies. This report highlights issues critical to the development of an objective, realistic, and scientifically balanced trichloroethylene health risk assessment.

Guidance for hazard characterization of trichloroethylene is presented in Chapters 2 through 10. Chapter 2 provides guidance for evaluating large sets of epidemiologic data. In Chapter 3, the committee applies this guidance as an example in its evaluation of the epidemiologic data on trichloroethylene and kidney cancer, and this example should help guide evaluations of other cancer risks. Chapter 3 also assesses new information on the kidney toxicity of trichloroethylene and its metabolites and potential modes of action. Chapters 4, 5, 6, 7, and 8 evaluate the key issues regarding liver toxicity and cancer, reproductive and developmental toxicity, neurotoxicity, respiratory tract toxicity and cancer, and immunotoxicity, respectively. However, the committee's review focused on mode-of-action information to understand how trichloroethylene might affect certain processes differently in different species. Chapter 9 discusses susceptibility to trichloroethylene and its metabolites, and Chapter 10 describes important factors in considering trichloroethylene in mixtures. Physiologically based pharmacokinetic models are evaluated in Chapter 11, and guidance is provided on future directions for model development. Finally, Chapter 12 considers issues related to dose-response assessment and quantitative assessment of risk.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!